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ABSTRACT 
NON-INSTURCTIONAL ROLES FOR NOTCH SIGNALING IN T CELL DEVELOPMENT 
Will Harrison Bailis 
Warren S. Pear 
 
Mammalian immunity requires the presence of a broad and diverse repertoire of antigen 
receptors that can recognize the virtually infinite number of pathogenic epitopes 
encountered over a lifetime of a host, along with the ability to flexibly mount organized 
and pathogen-specific immune responses, as orchestrated by cytokines and CD4+ 
helper T (Th) cells. The Notch signaling pathway plays a critical role both in the 
generation of the T cell repertoire and in Th cell differentiation. However, while Notch is 
well understood to instruct early T lineage development at the expense of alternate 
lineages, it is unclear how Notch regulates the differentiation of a common naïve 
progenitor into one of the many Th cell subsets. To clarify the molecular mechanism 
used by Notch to influence Th cell differentiation, the dynamics of Notch target binding 
and gene regulation were analyzed at early time points after T cell activation. Rather 
than finding that Notch signaling acts via the canonical instructional paradigm, these 
studies find that Notch acts as an unbiased integrator of environmental differentiation 
cues, such that it simultaneously promotes the differentiation of multiple inflammatory Th 
cell populations. These findings are supported by in vivo gain-of-function studies in 
which Notch signaling is constitutively activated in peripheral T cells. Unlike previous 
work showing that hyper-activation of the Notch pathway in T lineage progenitors yields 
aggressive T cell acute lymphoblastic leukemia, these mice go on to develop a lethal 
autoinflammatory disorder, resulting from the Notch pathway promoting the 
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differentiation of Th1, Th2, and Th17 cells. Additionally, these studies reveal that Notch 
signaling acts to destabilize regulatory T cell differentiation. Altogether, the work 
presented in this thesis evinces a novel non-instructional paradigm for Notch signaling, 
with broad implications for our understanding of Th cell differentiation, hematopoietic 
development, and cancer biology. 
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CHAPTER 1: Introduction 
The mammalian immune system is faced with the daunting challenge of generating a T 
cell receptor (TCR) repertoire large enough to cover every potential antigen a host will 
encounter in their lifetime from a limited number of progenitors. To accomplish this task, 
the few progenitors that enter the thymus must expand by several orders of magnitude in 
order to generate sufficient genetic material to survive antigen receptor recombination 
and TCR selection. Even after this is accomplished and a mature T cell enters the 
periphery, it will need to further differentiate to acquire its effector function. As cognate 
antigen recognition alone is not sufficient to clear a pathogen, adaptive immune cells 
must orchestrate a persistent and coherent response from both the adaptive and innate 
arms of the immune system, a task that requires the differentiation of CD4+ helper T (Th) 
cells into one of several subsets. Notch signaling is critical for both of these development 
processes, yet given the disparate demands of early and late T lineage development it is 
unclear how such a basic signaling module can organize two distinct differentiation 
mechanisms in the same lineage.  
 
While Notch signaling is understood to instruct early T lineage development, there is little 
consensus as to how the Notch pathway influences Th cell differentiation (Radtke et al., 
2013). Pioneering work with in vitro Th cell cultures yielded a paradigm in which the 
quality and fidelity of Th cell differentiation was governed by a linear model: a lineage 
inducing cytokine initiates a transcriptional program governed by a lineage defining 
transcription factor, which in turn licenses that cell to produce a lineage defining cytokine 
(O'Shea and Paul, 2010). While this highly stereotyped progression holds well in 
traditional in vitro differentiation systems, activated CD4+ T cells are often exposed to a 
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complex milieu of differentiating factors in vivo, each acting to push a Th cell down a 
different lineage path. Within this framework, the need for molecules that function to 
maintain signal within this noisy sea of differentiating cues becomes apparent. This 
thesis contends that the Notch pathway functions as one such signal-integrating module 
in the peripheral CD4+ compartment, distinct from its classical instructional role in early T 
lineage development. The findings presented suggest that Notch signaling exerts distinct 
mechanistic functions in early and late T lineage development and evinces a novel 
signal integration model for Notch in hematopoiesis.   
 
Overview of αβ-thymocyte development 
Although many hematopoietic progenitor cells have the capacity to become T cells, only 
a few migrate into the thymus (Bhandoola et al., 2007; Ng et al., 2009). Upon entry, 
these thymic emigrants respond to their new environment by proliferating extensively 
and initiating the T cell developmental program (Figure 1-1). The engagement of the T 
cell lineage program involves the inactivation of stem cell and progenitor genes, the 
activation of lineage specific factors, and the restriction of alternate fates (Rothenberg, 
2012). Intimately intertwined with the transcriptional reprogramming of thymocytes, the 
ongoing process of TCR rearrangement provides an additional level of regulatory 
complexity to T cell development and can begin even before progenitors enter the 
thymus (Allman et al., 2003; Igarashi et al., 2002).  
 
In this manner, T cell development can be divided into multiple stages by the initiation of 
the T cell transcriptional program and then several developmental checkpoints governed 
by the ordered rearrangement of the TCR and the selection of a thymocyte’s antigen 
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receptor against self-peptides (Figure 1-1). These developmental stages are defined by 
a set of surface markers that correlate with T cell maturation. The earliest populations of 
thymocytes are defined by their lack of expression of the co-receptors CD4 and CD8, 
and thus termed double negative (DN) cells. DN cells can be further subfractionated 
based upon their expression of CD25, the IL-2 receptor α-chain, and CD44, a cell 
adhesion receptor. The first cells to enter the thymus, DN1, are defined as CD25-CD44+ 
and progress to CD25+CD44+ DN2 cells, CD25+CD44- DN3 cells, and then CD25-CD44- 
DN4 cells. From DN1 through DN3, thymocytes rearrange the TCRβ, in a recombination 
activating gene (RAG) 1 and 2 dependent manner, and are held at a DN3 checkpoint 
that ensures functional TCRβ expression, termed β-selection. Subsequent to the DN 
stages of T cell development, thymocytes become double positive (DP) cells, 
characterized by the surface expression of CD4 and CD8. At the DP stage, thymocytes 
test a fully rearranged TCR against self-peptides presented on the major 
histocompatibility complex (MHC), such that all thymocytes are capable of recognizing 
self-MHC (positive selection), but do not activate upon engagement of a self-
peptide:MHC complex (negative selection). T cell development in the thymus ends when 
thymocytes successfully undergo selection and become single positive (SP) for either 
CD4 or CD8, as determined by the class of MHC that a thymocyte recognizes (MHC-I for 
CD8+ SP cells and MHC-II for CD4+ SP cells). 
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Figure 1-1: Stages of thymocyte development. Multipotent precursors are recruited to 
the thymus in a CLL21 and CLL25 dependent manner and are initially maintained by IL-
7 and SCF survival signals, supplied by cortical thymic epithelial cells (cTECs). These 
early precursors, DN1 cells, then initiate the T-lineage program upon Notch ligand 
engagement and progress to the DN2 stage. At the DN3 stage, thymocytes begin to 
express the pre-TCR complex, composed of pre-TCRα and TCRβ, and are licensed 
undergo β-selection and proceed to the DN4 stage. Once the TCRα locus is functionally 
rearranged and a mature TCR complex is expressed on the cell surface, DP thymocytes 
are subjected to positive selection by interacting with MHC bearing cTECs at the cortico-
medulary junction. DP thymocytes then progress to either the CD4+ SP or CD8+ SP 
stage, depending on the class of MHC their TCR recognizes. Thymocyte development is 
completed after self-reactive SP thymocytes are eliminated by negative selection 
through their recognitions of self-peptides presented by medullarly thymic epithelial 
cells. 
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Building the T lineage identity 
Multiple progenitor populations have been identified that can develop into T cells. 
However, the resident bone marrow lymphoid primed multipotent progenitors (LMPP) 
are understood to be the primary source of T cell precursors. Though they are enriched 
for T cell potential, LMPP’s can also give rise to myeloid cells, NK cells, and B cells, but 
not erythrocytes or megakaryoctyes (Yang et al., 2010). It is not until an LMPP 
expresses the chemokine receptors CCR7 and CCR9 that they are able to migrate to the 
thymus and begin T cell differentiation (Zlotoff et al., 2010). 
Upon entry, the thymic epithelium provides these recent thymic emigrants (DN1 cells) 
with a potent milieu of both soluble factors, such as interleukin 7 (IL-7) and stem cell 
factor, as well as membrane bound ligands, the most critical of which are the Notch 
ligands delta-like ligand 1 (Dll1) and Dll4, that support T cell development, proliferation, 
and survival. Until a thymocyte successfully rearranges the TCR β-chain, these epithelial 
derived signals sustain the T cell program during the earliest stages of development, 
DN1 through DN3. Though the thymic environment strongly favors αβ T cell 
development, other lineages can emerge from these pro-T cell populations and are 
supported within the thymus. The potential to differentiate into these alternate lineages is 
strongest at the DN1 stage and is almost completely lost by the DN3 stage (Rothenberg 
et al., 2010).  
This loss of multipotentiality is mirrored by a progressive termination of a stem cell-like 
transcriptional identity and the emergence of a T cell specific transcriptional program, 
composed of Notch1, TCF1, GATA3, and Bcl11b (Rothenberg, 2012). Global mapping 
of histones and RNA-seq analysis of developing thymocytes has revealed that this 
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progressive loss of stem/progenitor-specific gene expression results from a variety of 
histone transformations at multiple time points during development (David-Fung et al., 
2009; Tydell et al., 2007; Zhang et al., 2012). These data suggest that multiple 
biochemically and temporally distinct mechanisms govern the transition from a stem-like 
program to a T cell program, rather than a single switch (Zhang et al., 2012). Although 
much of the stem cell gene expression program is turned off, it is important to note that 
some genes sustain their expression throughout later stages of T cell development, such 
as Myb and Ikaros. While these sustained genes may play important regulatory roles, it 
has been suggested that they are unlikely to be rate-limiting factors for commitment 
(Rothenberg, 2012).  
 
Notch signaling 
Notch receptors are a family of evolutionarily conserved type-I transmembrane 
glycoproteins that play a critical role in large array of developmental processes, including 
multiple stages of T cell development (Bailis et al., 2013; Fang et al., 2007; Han et al., 
2002; Maillard et al., 2004; Radtke et al., 1999). Mammals possess four different Notch 
receptors (Notch1-4) that share homology with Drosophila Notch, and five Notch ligands. 
The mammalian ligands Delta-like 1, 3, and 4 (Dll1, 3, 4) are homologous to the 
Drosophila Delta, while Jagged1 and 2 are structurally similar to the Drosophila Serrate. 
The extracellular portion of Notch is responsible for ligand interaction and is composed 
of epidermal growth factor (EGF-like) repeats, LIN12 repeats (LNRs), and a membrane-
proximal heterodimerization domain (HD). In the absence of ligand, the LNR and the HD 
domains constitute a negative regulatory region (NRR) that ensures Notch receptors 
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remain membrane-bound and transcriptionally inactive. In response to ligand, the Notch 
intracellular domain (ICN) is released by proteolytic cleavage by gamma secretase and 
directly mediates signal transduction. ICN consists of a RAM domain, 7 ankyrin-like 
repeats (ANK), nuclear localization signal sequences, and a C-terminal PEST domain 
that regulates protein stability (Figure 1-2).  
 
While there are structural differences amongst the four Notch receptors, all are activated 
in a ligand-dependent manner and converge on the same core transcriptional complex. 
Upon Notch receptor-ligand interaction between two neighboring cells, a series of 
proteolytic cleavage sites become exposed that lead to cleavage of an extracellular site 
by ADAM family metalloproteases and subsequent cleavage of a transmembrane site by 
a gamma-secretase complex. This proteolytic processing frees ICN from the membrane, 
which then translocates to the nucleus and complexes with the transcription factor RBPJ 
and MAML. MAML then recruits co-activators, such as p300 and PCAF, to form a large 
multiprotein transcriptional activation complex. In this manner, Notch signaling results 
from the conversion of a transmembrane receptor into a transcriptional activator, 
allowing for rapid changes in target gene expression (Figure 1-3). 
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Figure 1-2: Structure of the mammalian Notch receptors and ligands. There are 
four mammalian Notch receptors, Notch1-4, each of which can be activated by one of 
four activating Notch ligands: Jagged1, Jagged2, Delta-like 1, and Delta-like 4. All four 
Notch receptors contain an extracellular domain composed of a series of EGF-like 
repeats followed by a LIN repeat containing region. The intracellular portion of the Notch 
receptors consists of a RAM domain, a series of ankyrin-like repeats (ANK), and a PEST 
domain that regulates protein stability. Notch1 and Notch2 additionally contain a 
intracellular transcriptional activation domain (TAD), unlike Notch3 or Notch4. 
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Figure 1-3: Schematic of Notch signaling. Notch signaling is initiated when a Notch 
receptor engages one of the four activating Notch ligands. This interaction exerts a 
mechanical force on the receptor, exposing a series of proteolytic cleavage sites. 
Metalloproteases and the γ-secretase complex then process the Notch receptor, 
liberating the intracellular Notch domain (ICN). Once released from the membrane, ICN 
is free to translocate to the nucleus where it interacts with its binding partners: RBPJ 
and MAML. The assembly of the Notch transactivation complex recruits co-activators 
(Co-A) that promote the transcription of Notch target genes. 
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Notch signaling and thymocyte development 
Although Notch1, 2, and 3 are all expressed in developing thymocytes, only Notch1 is 
both necessary and sufficient for T cell lineage commitment. Overexpression of the ICN1 
fragment of Notch1 in bone marrow progenitors causes ectopic T cell development and 
impairs B cell development, indicating a role for Notch in instructing the T rather than B 
fate decision (Figure 1-4) (Pui et al., 1999). Consistent with gain-of-function data, 
reciprocal loss-of-function experiments revealed that the inducible deletion of Notch1 or 
RBPJ or expressing a GFP-tagged, dominant-negative form of MAML (DNMAML) 
resulted in a severe block in T cell development at the DN stage and the accumulation of 
thymic B cells (Han et al., 2002; Maillard et al., 2004; Radtke et al., 1999). Conditional 
deletion models further mapped the stage-specific requirements for Notch signaling. 
Deletion of a floxed RBPJ gene at the DN2 stage, using Lck-cre, resulted in a 
developmental block at the DN3 stage, whereas use of a CD4-cre, which allows for 
deletion between the DN3 and DN4 stages, did not alter T cell development (Tanigaki et 
al., 2004). Moreover, the development of the DNMAML transgenic mouse provided the 
ability to track Notch inhibition at the single cell level via the GFP tag on DNMAML. 
Studies using these mice revealed that the developmental block observed in other loss-
of-function models occurred in DN3a cells at the β-selection checkpoint. Importantly, 
when DN3 cells from Lck-cre x DNMAML mice are intrathymically injected into 
recipients, DNMAML expressing thymocytes failed to give rise to appreciable numbers of 
DP or SP cells, clearly illustrating an absolute requirement for Notch signaling in the DN 
compartment (Maillard et al., 2006). Together, these data favor a model in which Notch 
signaling is essential up until a functional TCRβ is rearranged, but that persistent Notch 
signals are not essential thereafter. The findings discussed in this thesis will go on to 
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show that this transition from Notch-dependent to Notch-independent development at β-
selection is also accompanied by a switch in the oncogenic potential of the Notch 
pathway as well as a shift in its activity as an lineage instructing factor to a signal 
integrating factor that potentiates multiple fates. 
 
Notch signaling and the pre-TCR  
The timing of the transition from Notch-dependent to Notch-independent development 
suggests cross-talk between pre-TCR and Notch signaling, and research has revealed 
significant interaction between these two signaling pathways. Chromatin 
immunoprecipitation (ChIP) and reporter assays have shown that Notch signaling 
governs pre-TCR signaling by regulating Ptcra gene expression, which encodes a 
surrogate TCRα (pTa) that complexes with a functionally rearranged β-chain to facilitate 
pre-TCR signaling (Bellavia et al., 2007; Reizis and Leder, 2002). In addition to directly 
activating Ptcra expression, the Notch pathway also indirectly promotes Ptcra gene 
expression. RBPJ shares a DNA binding motif with the transcription repressor Ikaros 
and data suggests there is the potential for these two proteins to compete for binding 
sites (Hsu et al., 1994; Ono et al., 1998). Signaling through Notch3 promotes the 
expression of the RNA binding protein HuD, which results in enhanced generation of 
Ikaros isoforms that lack the capacity to bind DNA, through alternative splicing. In turn, 
these isoforms disrupt the activity of full-length Ikaros and mediate enhanced RBPJ 
binding at pTa and increased Notch-dependent expression (Bellavia et al., 2007). 
Finally, Notch signaling is also implicated in promoting rearrangement of the Tcrb loci, 
suggesting that Notch might regulate pre-TCR signaling at the level of both pre-TCRα 
and TCRβ expression (Ciofani et al., 2006; Wolfer et al., 2002). 
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While Notch signaling is a key regulator of of the pre-TCR machinery, the resulting pre-
TCR signals are essential for extinguishing Notch1 expression and mediating the 
progression to Notch-independent development. From the DN1 stage up through the 
DN3a stage of thymocyte development, Notch1 mRNA expression increases, and is 
regulated both by Notch1 itself and the E-proteins E2A and HEB (Ikawa et al., 2006; 
Yashiro-Ohtani et al., 2009). After β-selection, Notch1 expression sharply decreases in 
DN3b cells and remains low for the remainder of thymic development (Taghon et al., 
2006; Yashiro-Ohtani et al., 2009). Accordingly, Notch1 expression is rapidly and 
robustly downregulated upon PMA and ionmycin stimulation of Rag2-deficient DN3 cells, 
demonstrating that pathways downstream of the pre-TCR are capable of directly 
regulating Notch1 (Yashiro-Ohtani et al., 2009).  
This interplay between pre-TCR signaling and Notch1 expression is mediated by cross-
talk of these two pathways with E-proteins. While Notch signaling is the primary driver of 
the T lineage program, E-proteins are essential for coordinating the kinetics of Notch 
activity during thymocyte development. E2a deficiency results in decreased expression 
of Notch1 and Notch3 in fetal thymocytes and causes a developmental block at the DN3 
stage that can be rescued by overexpression of ICN1, placing Notch downstream of E2A 
(Ikawa et al., 2006). Moreover, E2A activity mirrors that of Notch1. E2A remains active 
until β-selection and pre-TCR signals promote the expression of the E-protein antagonist 
Id3, which disrupts E2A DNA-binding in later stages of development (Bain et al., 2001; 
Engel et al., 2001; Xi et al., 2006). Altogether, this creates a signal transduction circuit of 
a feedforward loop involving E2A-driven Notch1 expression, followed by Notch1 
autoregulation, which is then abolished by a negative feedback loop originating with pre-
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TCR signaling and terminating with Id3 antagonism of E2A and downregulation of 
Notch1 expression (Yashiro-Ohtani et al., 2009). 
In addition to the direct cross-talk between Notch and pre-TCR signaling, there is 
significant interplay between the two pathways at the level of survival and proliferation 
signals in DN3 cells. Both pathways display significant overlap with the AKT pathway 
and AKT signals can bypass the requirement for both Notch and pre-TCR signaling at 
the DN3 stage. Use of myristoylated AKT (myr-AKT), a membrane tethered and 
constitutively active form of AKT, can partially bypass the requirement for Notch 
signaling during β-selection (Ciofani and Zuniga-Pflucker, 2005). Furthermore, deletion 
of the PI3K/AKT signaling antagonist, phosphatase and tensin homologue (PTEN), 
permits the development of thymocytes from DN3 to DP cells, even in the absence of IL-
7 or pre-TCR signals (Hagenbeek et al., 2004). While AKT is downstream of pre-TCR 
signaling, Notch signaling does not directly activate the AKT pathway. Notch has been 
suggested to regulate AKT through multiple overlapping mechanisms. The canonical 
Notch target Hes1 binds the Pten locus and negatively regulates Pten in both normal 
and oncogenic T cell development (Palomero et al., 2007; Wong et al., 2012a). In a 
separate arm of Notch-AKT cross-talk, components of the mammalian target of 
rapamycin (mTOR) complex have been implicated as Notch pathway targets in the 
context of T-ALL (Chan et al., 2007; Lee et al., 2012). Finally, Notch has also been found 
to regulate the expression of receptors on thymocytes that engage the AKT pathway, 
such as the insulin-like growth factor 1 receptor and the IL-7Ra (Gonzalez-Garcia et al., 
2009; Medyouf et al., 2011). Collectively these data support a model in which Notch and 
pre-TCR signaling both provide critical inputs into the AKT pathway at the DN3 stage, 
leading to a transition from a Notch-mediated to a TCR-driven survival program. 
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Although there is overlap between Notch and pre-TCR signaling, the two pathways are 
not redundant in thymocyte development. Multiple groups have found that pre-TCR and 
TCR signaling are incapable of compensating for a loss of Notch. In an in vitro T cell 
differentiation system, retroviral expression of TCRβ or TCRαβ could not support T cell 
development in the absence of Notch signals. Moreover, the same study found that anti-
CD3e treatment or expression TCRβ in conjunction with constitutively active Lck, Fyn, 
Ras, or PKCα all failed to bypass the requirement for Notch, demonstrating that the 
inability to overcome a lack of Notch signaling doesn’t stem from a quantitative 
deficiency in pre-TCR signaling (Ciofani et al., 2004). Corroborating these in vitro 
findings, the DN3 block observed in Lck-cre x DNMAML mice cannot be rescued by the 
enforced expression of Tcrb or Tcra/b transgenes (Maillard et al., 2006). Conversely, 
Notch signaling by itself is incapable of overcoming the loss of pre-TCR signaling. RAG2 
deficient mice cannot generate the double-stranded breaks necessary for functional 
TCRβ rearrangement and thus display a block at the β-selection checkpoint; 
overexpression of ICN1 in these mice fails to restore development into the DP stage. 
Similarly, overexpression of ICN1 in SLP76 deficient mice, an essential downstream 
component of pre-TCR signaling, fails to drive the development of DP cells (Allman et 
al., 2001).  
While it remains unclear how these two pathways provide qualitatively distinct inputs into 
T cell differentiation, recent work has begun to clarify this issue. Detailed analysis of 
thymocyte expansion in the presence of cell cycle inhibitors has evinced an essential 
role for proliferation in the DN to DP progression. In the absence of Notch signaling, 
inducing proliferation by overexpression of either cell cycle machinery components or 
the Notch target Myc was capable of partially restoring in vitro development up to the DP 
15 
 
stage. In contrast, inducing proliferation by overexpressing cell cycle machinery was not 
sufficient to rescue development in the absence of a pre-TCR, as seen in Rag2 deficient 
thymocytes (Kreslavsky et al., 2012). Thus, the proliferative burst observed post-β-
selection is an essential downstream function of Notch during T cell development, 
whereas the pre-TCR pathway provides distinct, cell-cycle-independent signals.  
Altogether, these findings indicate that Notch and pre-TCR signaling each provide 
essential and non-redundant inputs into thymocyte development. 
 
Notch signaling and T-ALL 
The robust pro-survival and proliferative signals provided by the Notch pathway during 
normal thymopoiesis also make it a potent oncogene. Indeed, Notch was first discovered 
through the analysis of T-ALLs with a (7;9) translocation that resulted in the fusion of 
NOTCH1 on chromosome 9 to TCRB enhancer/promoter elements and the aberrant 
expression of a constitutively active, truncated nuclear Notch1 (Ellisen et al., 1991). 
When ICN1 is expressed in murine bone marrow progenitors, a rapid onset T-ALL 
emerges, demonstrating that Notch activation is sufficient for transformation (Figure 1-4) 
(Pear et al., 1996). 
 
While originally identified in tumors containing a TCRB translocation, this mutation was 
later found to be rare. Instead, the predominant NOTCH1 gain of function mutations, 
which are found in over 60% of human T-ALLs, occur via point and truncation mutations 
to the NOTCH1 gene itself (Weng et al., 2004). The majority of NOTCH1 mutations arise 
from point mutations to the NRR, which either destabilize the extracellular domain and 
permits ligand-independent cleavage of Notch1 and release of the ICN signaling peptide, 
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or they destroy the PEST domain, which prolongs the half-life of nuclear NOTCH1 
(Weng et al., 2004). Both classes of mutations allow cells to both increase the level of 
Notch signal received and sustain Notch signaling in environments that no longer 
support it. Although this increased “portability” of Notch signaling may the play a part in 
allowing transformed cells to escape the thymus, the dose of Notch signaling is a critical 
determinant of whether Notch acts as an oncogene or an effector of T cell development. 
Weak activating mutations to the NRR or PEST domain are sufficient to drive ectopic T 
cell development in transduced bone marrow cells and suppress B and myeloid 
differentiation, but fail to give rise to leukemia in the absence of additional genetic 
lesions. However, when multiple activating mutations to Notch are present or when ICN1 
is expressed, the resulting signals promote both ectopic T cell development and 
leukemia (Chiang et al., 2008). Thus, normal T cell development must walk a tenuous 
line between the ability of Notch1 to initiate and drive the T cell program and the capacity 
of Notch to act as a potent oncogene.  
 
The oncogenic potential of Notch signaling likely stems from its positioning as a key 
regulator of multiple pro-survival and pro-proliferative pathways. ChIP-on-chip profiling 
after Notch inhibition in gamma-secretase inhibitor (GSI) treated T-ALL cell lines 
revealed that more than 40% of Notch-responsive loci were effectors of cell metabolism 
and protein biosynthesis (Palomero et al., 2006). Among these genes, c-Myc has been 
identified as a critical Notch target in T-ALL (Palomero et al., 2006; Sharma et al., 2006; 
Weng et al., 2006). Expression of c-Myc rescues T-ALL cell lines from Notch withdrawal 
and c-Myc inhibitors block the ability of ICN1 to rescue T-ALL cell lines from GSI 
treatment, demonstrating that c-Myc is both necessary and sufficient for Notch1’s 
leukemogenic functions (Palomero et al., 2006; Sharma et al., 2006; Weng et al., 2006). 
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In addition to c-Myc, Notch signaling has also been suggested to regulate the NF-κB and 
AKT pathways. Ectopic expression of ICN1 in bone marrow progenitors promotes the 
nuclear localization of NF-κB, the expression of NF-κB components, and the expression 
of NF-κB target genes. Although inhibition of NF-κB impairs the growth of Notch1-
dependent human T-ALL cell lines, NF-κB is not sufficient to drive T-ALL (Vilimas et al., 
2007). Given that NF-κB signaling is necessary but not sufficient for T-ALL, NF-κB may 
act in collaboration with Notch1 to promote c-Myc expression, as studies have identified 
NF-κB binding sites in the Myc promoter (Park and Wei, 2003). In parallel to its affects 
on NF-κB, Notch signaling has also been implicated in regulating the AKT pathway in 
cancer. The Notch-Hes1-PTEN axis seen during thymocyte development is an important 
mediator of Notch driven T-ALL. Loss of PTEN is a frequent occurrence in GSI-resistant 
T-ALLs and is sufficient to rescue the survival and proliferation defects observed in GSI 
treated, Notch-dependent T-ALL cell lines, indicating AKT is an important downstream 
effector of Notch in T-ALL (Palomero et al., 2007). Accordingly, AKT signaling has been 
found to be a critical downstream mediator of Notch1-driven glycolysis (Landor et al., 
2011). Moreover, multiple reports have linked Notch signaling to the AKT pathway 
member mTOR. Loss of Rictor, a component of mTORC2, significantly increases 
median survival and reduces leukemic cell organ infiltration in a murine model of Notch1-
induced T-ALL (Lee et al., 2012). Corroborating this finding, GSI treatment or expression 
of DNMAML in T-ALL cell lines results in the inhibition of multiple components of mTOR 
signaling that could be rescued by expression of ICN1 (Chan et al., 2007). Altogether 
these data indicate that while c-Myc is the primary mediator of Notch-driven T-ALL, 
Notch signaling regulates multiple pathways with known oncogenic roles and likely 
promotes transformation by the overlapping pro-survival and pro-proliferative inputs from 
these signals. Chapter 3 will review data illustrating that the oncogenic activity of Notch 
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is lost after β-selection, opening the way for future studies to identify the molecular and 
cellular contexts in which Notch can transform cells. 
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Figure 1-4: Notch signaling and T lineage development. Notch signaling instructs T 
cell development in LMPP’s at the expense of B cell differentiation. The pathway 
remains active from the DN1 through the DN3 stage of thymocyte development, where it 
is a critical regulator of proliferation and cell survival. Hyper-activation of Notch signaling 
during this period results in the potent induction of T-ALL. Notch signaling is 
extinguished once a thymocyte successfully passes through the β-selection checkpoint 
and the remainder of thymic development is understood to be Notch-independent. When 
a mature, naïve CD4+ T cell enters the periphery and becomes activated, Notch 
signaling is reinitiated and understood to play an important role in subsequent Th cell 
differentiation decisions; however it remains unclear how or whether Notch instructs the 
fate of these various subsets. 
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Peripheral CD4+ T cell differentiation 
The Th1-Th2 paradigm and the linear instruction model 
Though CD4+ T cell diversity has long been appreciated, our ability to delineate the 
discrete boundaries that define individual Th cell populations has waxed and waned as 
our understanding of the complex relationship between these subsets has evolved. Initial 
efforts to classify Th cell subsets ranged from the use of cell surface antigens (Arthur 
and Mason, 1986; Bottomly, 1988; Morimoto et al., 1985a; Morimoto et al., 1985b), to 
designations based on short- and long-term survival post-thymectomy (Kappler et al., 
1974), and even classifying Th cells based on the use of antigen recognition versus B 
cell idiotype recognition (Bottomly and Mosier, 1979; Janeway et al., 1977). While these 
methods were effective in fractionating the CD4+ T cell compartment, they did not yield 
consistent functional immune correlates (Mosmann and Coffman, 1989). 
 
Following the establishment of the first functional T cell hybridoma lines and the 
relentless efforts to identify and characterize the growing world of “lymphokines,” Tim 
Mossman and Richard Coffman were equipped with the tools necessary to establish the 
modern Th cell paradigm (Kontiainen et al., 1978; Mosmann and Coffman, 1989). The 
observation that T cell hybridoma lines separated into two distinct groups based on 
cytokine production and that this pattern of cytokine production could predict the mode of 
B cell help given revolutionized our understanding of host immunity (Mosmann et al., 
1986). Moreover, the findings that these disparate Th cell cytokine phenotypes were 
stable over periods as long as 18 months and failed to interconvert provided compelling 
evidence that these populations were distinct lineages (Mosmann and Coffman, 1989). 
Subsequent studies demonstrating that this method of Th cell fractionation was sufficient 
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to explain whether certain inbred mouse strains were susceptible to specific classes of 
pathogens, based on the cytokine bias of Th cell from these mice, illustrated that 
cytokines and Th cell subtype – not just antigen/MHC specificity – were critical 
determinants of pathogen-specific immune responses (Else and Grencis, 1991; Heinzel 
et al., 1989; Locksley et al., 1987; Sadick et al., 1987; Scott et al., 1988). 
 
Once the precursor-product relationship for both Th1 and Th2 cells was mapped back to 
a common progenitor – the thymectomy-sensitive, naïve T cell – efforts became focused 
on understanding how a bifurcation in fate choice could arise in a developmentally 
mature cell type (Seder and Paul, 1994). It was appreciated early that exogenous factors 
played a key role in differentiation. The signature cytokines of each Th cell subtype were 
found to act in an autocrine manner to reinforce their corresponding program and inhibit 
the adoption of the alternate phenotype (Fernandez-Botran et al., 1988; Gajewski and 
Fitch, 1988). Furthermore, the observation that IL-12 was necessary and sufficient to 
induce Th1 differentiation via STAT4 (Gazzinelli et al., 1993; Hsieh et al., 1993; Kaplan 
et al., 1996b; Thierfelder et al., 1996) and that IL-4 via STAT6 was necessary and 
sufficient for Th2 differentiation (Betz and Fox, 1990; Hou et al., 1994; Kaplan et al., 
1996a; Le Gros et al., 1990; Swain et al., 1990) suggested that these two population 
differentiated in response to unique signaling modules, despite shared pathways 
downstream of the TCR and co-stimulation. Finally, the discovery of Tbet and Gata3 as 
factors that were not only obligate for Th1 and Th2 differentiation, respectively, but could 
impose Th1 or Th2 phenotypes on already differentiated cells cemented the notion that 
discrete, mutually-exclusive Th cell subsets existed and solidified a linear instruction 
model of Th cell differentiation that has come to dominate the field (Figure 1-5) (Szabo et 
al., 2000; Zheng and Flavell, 1997). 
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Many aspects of this model have been repeatedly supported by findings in the literature, 
demonstrating its predictive utility, particularly in vitro and within the bi-polar Th1-Th2 
paradigm. The linear instruction hypothesis contends that differentiated cells will have 
distinct functional programs, governed by unique transcriptional networks downstream of 
unique exogenous factors that are self-reinforcing and antagonistic to alternate fates. 
Indeed, cytokine production by Th cells is often dominated by either IFNγ or IL-4 in a 
large number of classically used infection models (Else and Grencis, 1991; Heinzel et 
al., 1989; Locksley et al., 1987; Sadick et al., 1987; Scott et al., 1988). Moreover, the 
ability of Th cells to provide host protection in these models requires animals to have the 
capacity to express the appropriate fate-specifying cytokines or cytokine receptors, the 
signal transducers that are downstream of those cytokine receptors, and a discrete and 
specific network of transcription factors regulated by those signal transducers (Altare et 
al., 1998; Mattner et al., 1996; Rosas et al., 2006; Stamm et al., 1999; Urban et al., 
1998). Not only does each Th cell subset require these transcription factor networks, but 
enforced expression of one network has been shown to destabilize the activity of others 
(Szabo et al., 2000; Zheng and Flavell, 1997). Altogether, the strength of the linear 
instruction hypothesis has led to its use as a predictive mechanistic model for 
experimental findings for nearly a quarter century. 
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Figure 1-5: The linear instruction model of Th cell differentiation. Naïve CD4+ T 
cells differentiate in response to unique cytokine mixtures soon after activation. 
Cytokines stimulate the activation of signal transducers that in turn promote the 
expression of lineage defining “master regulator” transcription factors. The master 
regulators imprint lineage identity, as defined by the production of a signature cytokine, 
and restrict potential for alternate Th cell fates. STAT4 acts downstream of IL-12 to 
induce Tbet expression and impose the Th1 identity. IL-4 signaling activates STAT6, 
resulting in Gata3 expression and Th2 differentiation. A combination of the 
immunoregualtory factor TGFβ and the immunoinflammatory cytokine IL-6 results in 
STAT3-dependent Rorγt expression. Finally, the Treg cell identity is imprinted by the 
expression of Foxp3, which is induced by TGFβ plus IL-2 and requires STAT5. 
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More lineages, more problems: the linear instruction model challenged 
Despite the durability of this hypothesis, many experimental observations are largely 
inconsistent with its implicit predictions. Researchers have long been aware that many 
human Th cell populations fail to fall within these mutually exclusive bins, with the 
exception of instances of severe inflammation (Bucy et al., 1994; Kelso, 1995; Maggi et 
al., 1988; Romagnani, 1991). Even in the in vitro systems employed by Mosmann and 
Coffman, cells failed to show cytokine production or transcription patterns on a single 
cell level that were consistent with single, dominant transcriptional programs (Bucy et al., 
1994). More recently, the identification of IL-17A producing Th17 cells (defined by Rorγt 
and induced in the presence of TGFβ plus IL-6) and TGFβ producing Treg cells (defined 
by Foxp3 and induced in the presence of TGFβ plus IL-2) has presented the model’s 
greatest challenge (Bettelli et al., 2006; Brunkow et al., 2001; Chatila et al., 2000; 
Fontenot et al., 2003; Ivanov et al., 2006). Although researchers have shown that these 
populations can be generated in vitro based on first principles of the linear instruction 
hypothesis,  the identification of Th17 and Treg cells has called several key aspects of 
this model into question. 
 
An essential component of the linear instruction hypothesis is that each Th cell identity is 
defined by the expression of unique cytokine profiles and the identity of each subset is 
actively maintained by the expression of a single “master regulator.” Initial findings from 
Th17 and Treg studies were consistent with these axioms, however the existence of Th 
cell populations that produce multiple lineage defining cytokines and transcription factors 
is now widely appreciated. Th17 cells have been shown not only to have the capacity to 
produce both IL-17A and IFNγ concurrently, but also the ability to lose IL-17A expression 
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and solely produce IFNγ (Algood et al., 2007; Bending et al., 2009; Chen et al., 2007; 
Lee et al., 2009; Shi et al., 2008). Consistent with cytokine production data, Th17 cells 
have also been found to simultaneously express Tbet and Rorγt (Annunziato et al., 
2007; Shi et al., 2008). In addition to the mixed Th cell profile observed in Th17 cells, 
Treg cells have also been found to exhibit features of Th cell duality. Given their shared 
requirement for TGFβ in differentiation, it is not surprising that Th cells can co-express 
Foxp3 and Rorγt and that Foxp3+ cells can produce IL-17A (Xu et al., 2007; Yang et al., 
2008). Perhaps more unanticipated, Tregs are now known to have the potential to 
express the Th1 and Th2 “master regulators,” Tbet and Gata3. Foxp3+ cells have been 
found to co-express Tbet and IFNγ and these factors are understood play an important 
role in Treg localization and repressor function during type-1 inflammatory responses 
(Koch et al., 2009; Oldenhove et al., 2009; Sawitzki et al., 2005; Stock et al., 2004). 
Similarly, not only can Tregs co-express Foxp3 and Gata3, but Gata3 expression in 
Tregs has also been found to play an essential role in Treg biology and may even act to 
limit inflammatory Th cell differentiation (Rudra et al., 2012; Wang et al., 2011; Wohlfert 
et al., 2011). Further complicating the role of Gata3 as the “master regulator” of Th2 
differentiation, Gata3 expression is also required for the differentiation of IL-9 producing 
Th9 cells (Dardalhon et al., 2008; Veldhoen et al., 2008). While IL-9 secreting cells can 
produce IL-4 like Th2 cells, Gata3+IL-4- Th9 cells can exist as a population independent 
of Th2 cells and there are even IL-17A+ cells that have the capacity to produce IL-9 
(Elyaman et al., 2009; Licona-Limon et al., 2013). Altogether, these data are 
fundamentally incompatible with the linear instruction hypothesis and are more indicative 
of a continuum of states and/or overlapping functional programs. 
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These findings not only suggest that Th cells are capable of simultaneously supporting 
multiple programs to generate nuanced responses, but also illustrate a second 
irreconcilable axiom of the linear instruction hypothesis: that the unique cytokine 
signatures of Th cells are representative of discrete lineages. By definition, a cell lineage 
represents a distinct developmental progression resulting in a stable functional grouping 
of cells. The extent to which functional groups can interconvert dictates whether multiple 
cell populations represent true lineages (i.e. T versus B lineage cells) or whether they 
instead represent modular functional programs within a single lineage (i.e. IgE versus 
IgG producing B cells). As described above, Th cells have the capacity to change 
cytokine production and transcriptional network profiles. The fact that this had only been 
observed with regard to the Th17 and Treg phenotypes had previously been cited as 
evidence to argue that Th1 and Th2 cells did in fact represent distinct cell lineages (Zhou 
et al., 2009b). However, recent work demonstrates that interferons and IL-12 can 
reprogram Th2 cells into a hybrid Gata3+Tbet+ state during viral infection, evincing that 
these two Th cell types are in fact not stable, mutually exclusive lineages, but rather are 
reprogrammable, semi-stable functional modules (Hegazy et al., 2010). Importantly, this 
has not only been shown functionally but also at the level of epigenetic regulation. ChIP-
seq analysis of Th cell populations has revealed that, rather than shutting down 
transcriptional programs for alternate fates as has been observed in similar analyses of 
related lineages, differentiated Th cells maintain signature genes for alternate programs 
in a poised chromatin conformation (Cedar and Bergman, 2011; Wei et al., 2009). Thus 
Th cell type flexibility appears to be a normal feature of CD4+ T cell activation. 
 
In light of the mounting evidence that Th cell differentiation is unlikely to operate under 
the linear instruction model, it is worthwhile reconsidering the Th subtype-specific 
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instructional roles that have been ascribed to a wide variety of exogenous cues that are 
received by activated CD4+ T cells. Activated CD4+ T cells integrate a multitude of 
external signals in addition to cytokines, including signals derived from the TCR and co-
stimulatory molecules. Although originally described as instructive, these molecules 
have all been found to play a role in the differentiation of multiple Th cell subsets.  
 
Antigen dose and altered peptide ligand studies have been used to argue that TCR 
signal strength instructs Th1 or Th2 differentiation: with high levels of TCR stimulation 
suggested to instruct Th1 differentiation and weak TCR stimulation suggested to instruct 
Th2 differentiation (Constant and Bottomly, 1997; Zhu et al., 2010). In stark contrast to 
these peptide-based studies, in vivo infection models have shown that high levels of 
infection correlate with higher levels of Th2 cytokine production, whereas lower levels of 
infection result in increased Th1 cytokine production, with pathogens ranging from 
Leishmania major to Trichuris muris giving the same result (Bancroft et al., 1994; 
Bretscher et al., 1992; Nicholson et al., 1995; Sarzotti et al., 1996). While there are 
obviously many confounding factors that affect our ability to interpret these in vivo 
infection studies, it is clear that antigen dose itself is neither necessary nor sufficient to 
instruct Th cell type choice, in contrast to cytokines in these models. Moreover, O’Garra 
and colleagues observed that both very high and low doses of ovalbumin peptide 
promote Th2 differentiation, suggesting that the influence of TCR signaling on Th cell 
differentiation is not simply a matter of signal strength (Hosken et al., 1995). Finally, the 
Th2-biasing activity of altered peptide ligands that diminish TCR signal strength is highly 
dependent on the cytokine environment, with higher doses IL-2 being sufficient to 
override these effects (Tao et al., 1997). Hence, while TCR signaling can influence both 
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Th1 and Th2 differentiation under certain conditions, it does not display activities 
consistent with an instructional pathway. 
 
Like TCR signaling, the linear instruction hypothesis has been applied to the role of co-
stimulatory molecules in Th cell differentiation. The B7 family of co-stimulatory molecules 
– consisting of CD28, CTLA4, and ICOS – play an essential role in T cell activation and 
have also been argued to instruct Th cell differentiation (Constant and Bottomly, 1997; 
Zhu et al., 2010). Although multiple studies initially implicated CD28 and CTLA4 as 
instructive signals, these molecules were found to play unbiased roles in Th cell 
differentiation and instead are critical tuners of T cell activation (Constant and Bottomly, 
1997; Zhu et al., 2010). ICOS has similarly been suggested to instruct Th2 
differentiation, with ICOS deficient mice reported to display severely impaired IL-4 
production (Dong et al., 2001). However, subsequent studies have illustrated a complex 
role for ICOS in Th cell biology. Inhibition of ICOS signaling has been found to both 
positively and negatively regulate IL-4 and IFNγ production in in vivo models as well as 
promote or protect against the Th17-mediated disease model experimental autoimmune 
encephalomyelitis, depending on the timing of ICOS inhibition (Harada et al., 2003; 
Rottman et al., 2001; Sporici et al., 2001). Moreover, ICOS signaling has also been 
shown to be critical in Treg differentiation and/or function, where it has even been found 
to be necessary for limiting Th2 responses (Akbari et al., 2002; Herman et al., 2004). 
Collectively, these findings indicate that, while both TCR and co-stimulation are critical 
inputs that can influence Th cell differentiation, they do not behave instructionally and 
their diverse activities in multiple Th cell populations highlights the existence of a large, 
shared signaling network amongst the Th cell subsets. 
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As discussed above, outside of the role that highly defined mixtures of cytokines play in 
Th cell differentiation in vitro, the vast majority of evidence suggests that Th cell 
differentiation operates as a series of overlapping functional modules coordinated by a 
large, shared network of signaling pathways that are integrated to provide semi-stable 
effector states. Within this framework, the need for molecules that help integrate these 
inputs into coherent outputs becomes just as great as the need for cytokines in enforcing 
specific functional outcomes. Although initial efforts were spent attempting to fit the 
Notch signaling pathway into the linear instruction model, this thesis contends that the 
Notch pathway instead acts as an unbiased integrator of environmental differentiation 
cues. 
 
Notch signaling in peripheral CD4+ T cell differentiation 
Notch as an instructor of Th1 versus Th2 cell differentiation 
Given the Notch pathway’s unequivocal instructional role in T lineage commitment from 
normal hematopoietic progenitors and in launching the T-ALL program from 
dysregulated precursors, it is not surprising that this classical instructional paradigm was 
also applied to its role in Th cell differentiation. With only Th1 and Th2 cells appreciated 
at the time, Amsen and colleagues hypothesized that Notch signaling instructed this 
process much like it did in other bipotential fate decisions.  They went on to find that 
while Notch pathway did display some characteristics of an instructional pathway, the 
outcome of Notch signaling depended on the type of presenting Notch ligand. Delta-like 
ligands expressed on MHC-bearing fibroblasts were shown to instruct Th1 differentiation 
and limit Th2 differentiation, while Jagged ligands were found to instruct Th2 
differentiation. Intriguingly, they also observed that LPS treatment could induce Notch 
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ligand expression on dendritic cells (DCs) in a TLR4 dependent manner, and that 
Jagged and Delta-like ligands could each be selectively expressed by stimulation with 
unique stimuli, fitting with a prevailing model that the caliber of Th cell responses is 
patterned by the activating stimuli antigen presenting cells receive. Despite these 
findings, RBPJ deficiency only affected the ability of LPS treated DC’s to promote IL-4 
production, even though this stimulus induced the expression of both Delta-like and 
Jagged ligands. Reciprocally, expression of ICN1 in T cells only resulted in increased 
Th2 differentiation (Amsen et al., 2004). Further complicating these findings, another 
study using a similar Notch ligand expression system found no instructive capacity for 
either Jagged or Delta-like ligands. Instead, they argued for a model in which Notch 
behaves selectively to promote Th1 or Th2 differentiation, but in a manner entirely 
dictated by upstream cytokine signaling (Ong et al., 2008). There is now also evidence 
that Delta-like ligands are key regulators of Th2 responses in vivo and that Jagged 
ligands can promote Th1 differentiation (Jang et al., 2010; Le Friec et al., 2012; 
Mukherjee et al., 2014). Nevertheless, this seminal study established the ligand 
instruction model, which would become the prevailing hypothesis for the complex role 
Notch signaling plays during Th cell differentiation. 
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Figure 1-6: The Notch ligand instruction model. Notch ligands have been proposed 
to differentially instruct either Th1 or Th2 differentiation. In this model, Delta-like ligands 
are thought to instruct Th1 differentiation by promoting the transcription of Tbx21 and 
Ifng and by inhibiting Th2 differentiation downstream of the IL-4R, though the 
transcriptional and inhibitory activity of the Notch pathway in this setting has not formally 
been shown. Similarly, Jagged ligands are thought to instruct Th2 differentiation by 
directly promoting the transcription of Il4 and the transcription of Gata3 from exon 1-a. 
However, the Gata3-1a transcript represents a minor fraction of the total Gata3 mRNA, 
with the Gata3-1b isoform being the dominant transcript, regulated downstream of IL-4R 
signaling. 
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Subsequent studies similarly argued for an instructional model, however they disagreed 
with regard to which Th cell subset Notch signaling promoted. Oral administration of γ-
secretase inhibitors (GSI) or pre-treatment of T cells with GSI was reported to severely 
inhibit IFNγ production by Th1 differentiated cells, while having no effect on IL-4 
production under both Th2 and non-polarizing conditions. The same study also found 
that GSI treatment inhibited Tbx21 (Tbet) transcription, but not Gata3, and expression of 
ICN1 could enhance IFNγ production and Tbx21 transcription, even in Th2 differentiated 
cells, via binding to the Tbx21 promoter (Minter et al., 2005). In addition to reported roles 
for Notch1 in promoting Th1 differentiation, Notch3 has also been suggested to instruct 
the development of this Th subset. Exogenous expression of ICN3 in T cells resulted in 
enhanced Th1 differentiation at the expense of Th2 differentiation, and the same effect 
was observed upon treating mice or T cells with an activating Dll1-Fc fusion protein 
(Maekawa et al., 2003). Further highlighting a role for Notch signaling in Th1 
differentiation, LPS treated CD8- DC’s have been shown to promote Th1 differentiation 
independent of IL-12 production. This phenomena has been suggested to be due to 
increased expression of Dll4 on CD8- DC’s that in turn results in Dll4-dependent Th1 
differentiation, however the requirement for Notch signaling in the receiving T cells was 
never tested (Skokos and Nussenzweig, 2007). 
 
In spite of evidence supporting Notch as a selective instructor of Th1 differentiation, 
multiple in vitro and in vivo loss-of-function studies have contended the contrary. In 
addition to data from RBPJ deficient T cells discussed above, work using CD4-cre x 
DNMAMLFL/FL T cells also found that Th2 differentiation was severely impaired when 
Notch signaling was inhibited, while Th1 differentiation remained intact. Moreover, these 
mice were resistant to L. major infection, a Th1-dependent model, but susceptible to T. 
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muris infection, which requires a Th2-dependent immune response for protection (Tu et 
al., 2005). Corroborating these findings, CD4-cre x RBPJFL/FL mice exhibit a significantly 
impaired Th2 response and an enhanced Th1 response following immunization and 
restimulation with Schistosoma mansoni egg extract and have also been found to be 
resistant to L. major infection (Amsen et al., 2007; Auderset et al., 2012). Not only has 
loss of Notch signaling been found to impair Th2 differentiation, but expression of ICN1, 
and to a lesser extent ICN2-4, robustly and selectively promotes Th2 differentiation in 
vitro (Amsen et al., 2007; Fang et al., 2007).  
 
At the transcriptional level, Notch is thought to mediate this instructive capacity by 
directly regulating the Il4 and Gata3 loci. Notch1 binds to and directly regulates Il4, as 
seen in ChIP analysis and luciferase assays (Amsen et al., 2004; Fang et al., 2007). 
This activity is dependent on the 3’ Il4 enhancer, HS5: when Notch signaling is enforced 
in transgenic T cells bearing an Il4 minilocus, transcription from the minilocus is only 
enhanced when constructs contain the HS5 (Amsen et al., 2007). Notch regulation of Il4 
also requires Gata3 activity, but can occur in the absence of STAT6. Expression of ICN1 
in Gata3-deficient T cells or in the presence of a dominant-negative Gata3 failed to 
promote IL-4 protein expression (Amsen et al., 2007; Fang et al., 2007). Moreover, while 
expression of ICN1 alone had a minimal capacity to enhance IL-4 production in Th1 
cultures, co-expression of Gata3 and ICN1 synergistically promoted IL-4 production in 
Th1 cells, in a STAT6-independent fashion (Fang et al., 2007). While these findings 
established Notch as a regulator of the Th2-defining cytokine, they also raise questions 
over the Th2 instructing capacity of the Notch pathway. Although ICN1 can induce IL-4 
expression in activated T cells and even reprogram Th1 cells, Notch signaling itself was 
not sufficient for either of these functions and required the potent stabilizer of Th2 
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identity, Gata3. In fact, Notch potentiates Th1 differentiation in Gata3-/- T cells (Amsen et 
al., 2007). These data may instead suggest that Notch lacks any instructional activity 
alone and rather cooperates with other regulators of Th cell programming. 
 
Not only has Notch been shown to regulate Il4 in cooperation with Gata3, but it has also 
been found to directly regulate Gata3 itself. Gata3 can be expressed as two transcripts 
through two different variants of exon 1: Gata3-1a and Gata3-1b (Asnagli et al., 2002). 
As shown by both ChIP and EMSA, the Notch transcriptional activation complex can 
associate with both exons 1a and 1b. In addition, GSI treatment inhibits the 
accumulation of Notch at both regions, indicating that Notch has the potential to 
dynamically modulate Gata3 expression through both transcripts (Amsen et al., 2007; 
Fang et al., 2007). Although expression of DNMAML decreased transcription at both 
sites after seven days of culture, expression of ICN1 was sufficient to potently drive 
Gata3-1a transcription after only 36 hours and failed to activate transcription at Gata3-
1b, suggesting that Notch only regulates expression of transcripts initiated at exon 1a 
(Fang et al., 2007). Despite compelling data indicating that the Notch pathway can 
directly regulate Gata3 expression, it’s inability to drive expression at Gata3-1b does not 
fit with an instructional role for Notch. While both transcripts are expressed in Th2 cells, 
Gata3-1b is expressed within the first 24 hours of activation, whereas expression from 
Gata3-1a doesn’t begin until day 3 post activation (Asnagli et al., 2002; Yu et al., 2009). 
Moreover, Gata3-1b transcripts are much more abundant that the Gata3-1a variant (Yu 
et al., 2009). Thus, although Notch can regulate Gata3-1a, the kinetics and magnitude of 
expression are incompatible with an instructive role for Notch in Th2 differentiation, via 
Gata3. Chapter 2 will discuss data suggesting that Notch does not instruct Th cell 
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differentiation, but instead acts to simultaneously promote the differentiation of Th1, Th2, 
and Th17 cells by sensitizing cells to exogenous differentiating cues. 
 
Notch and non-classical Th cell subsets 
While studies conflicted over whether Notch instructed Th1 versus Th2 differentiation, 
the ligand instruction model was made even more tenuous by additional reports 
implicating Notch in other Th cell populations. Suggesting a role for Notch in Th17 
biology, recombinant-Dll4 stimulation can promote Th17 differentiation in vitro and TLR 
stimulated APCs can enhance Th17 differentiation in a Dll4 and Notch dependent 
manner. This effect was suggested to be mediated by Enhanced STAT3 signaling as 
well as by the ability of the Notch transactivation complex to bind to the Rorc (Rorγt) 
promoter (Mukherjee et al., 2009). A second corroborating study similarly showed that 
siRNA knockdown of Notch1 or GSI treatment of human and mouse T cells inhibited in 
vitro Th17 differentiation. This study not only confirmed Notch binding to Rorc by ChIP, 
but also identified Il17a as a probable direct target (Keerthivasan et al., 2011). Findings 
from both these studies indicate that Notch signaling regulates Th cell differentiation 
beyond the Th1/Th2 paradigm and that Dll4 can promote the differentiation of non-Th1 
subsets, which is not consistent with predictions from the ligand instruction model. 
 
In addition to Th17 differentiation, Notch signaling has now been suggested to regulate 
the putative Th cell subsets Th9 and T follicular helper (Tfh) cells (defined by Bcl6 
expression and IL-21 production) (Crotty, 2011). CD4-cre x Notch1FL/FLNotch2FL/FL mice 
display impaired IL-9 secretion under both Th9 and Th17 conditions. Conversely, 
Jagged ligand stimulation or ICN1 expression results in enhanced IL-9 production. This 
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effect on IL-9 is direct: Notch binds to the Il9 promoter, where it synergizes with Smad3 
to induce transcription, as seen in ChIP and luciferase assays (Elyaman et al., 2012). 
While the data supporting a role for Notch in Th9 biology is compelling, it is unclear the 
extent to which Notch is involved in the differentiation or the function of this subset. 
Moreover, the extent to which Th9 cells represents a bona fide Th cell subset or IL-9 
production is a functional module that can be overlaid on top of Th2 and Th17 
differentiation remains undetermined (Murphy and Stockinger, 2010). 
 
Like Th9 cells, it is unclear if Tfh cells should be characterized as a distinct Th cell 
subset or as a program parcel that can further specialize Th1 and Th2 cells (Murphy and 
Stockinger, 2010); nonetheless recent work suggests that Notch signaling may be 
involved in Tfh biology. CD4-cre x Notch1FL/FLNotch2FL/FL display severely impaired Tfh 
responses after immunization with peptide, L. mexicana, or S. mansoni eggs. Mixed 
bone marrow chimeras similarly displayed reduced Tfh differentiation in immunization 
models, however the presence of WT cells partially rescued this defect, suggesting this 
is not entirely a cell autonomous phenotype. The finding that Notch signaling modulates 
the balance of Bcl6 and Blimp1 (a transcription factor known to antagonize Bcl6 activity) 
in activated T cells offers one potential explanation for this observation, but this was 
shown to be an indirect effect. Further complicating this study, CD4-cre x 
Notch1FL/FLNotch2FL/FL mice have compromised germinal center architecture and cell 
number following immunization or infection and are known to have defects in IL-4 
production (Auderset et al., 2013). Given Tfh cells require normal germinal center 
function to properly differentiate, it is unclear whether these Tfh defects are caused by or 
are responsible for complications in germinal center formation (Crotty, 2011). Until the 
relationship of Tfh cells to the other known Th cell subsets is established, it will be 
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difficult to resolve whether these findings truly indicate a role for Notch in Tfh 
differentiation or if they instead result from impaired Th1 or Th2 differentiation due to 
loss of Notch signaling. 
 
While the role Notch signaling plays in inflammatory Th cell differentiation is disputed, 
there is no greater clarity as to how Notch influences Treg biology. Both Notch1 and 
Notch 3 have been suggested to promote Treg differentiation. Lck-cre x ICN3FL/FL mice 
display a nearly twenty-fold expansion of CD25+Foxp3- cells, but also exhibit a roughly 
three-fold expansion of CD25+Foxp3+ cells. Moreover, these cells demonstrate elevated 
suppressor function. This expanded Treg population is lost when ICN3-transgenic mice 
are crossed to Ptcra-/- mice, indicating that these cells are likely naturally occurring 
Tregs. It is worthwhile noting that these mice also develop T-ALL, making it difficult to 
determine whether these effects are secondary to additional complications in these mice 
(Anastasi et al., 2003; Campese et al., 2009). A second study found that GSI pre-
treatment of T cells or expression of an antisense Notch1 transgene resulted in 
decreased Treg differentiation in vitro. However, cleaved Notch1 protein was still present 
in significant quantities upon GSI treatment and Notch1 antisense expression, 
suggesting that the phenotypes observed cannot solely be explained by an absence of 
Notch signaling. The same study also found that Notch1 can bind to the Foxp3 promoter 
and GSI treatment depleted Notch1 from this region, however histone acetylation at both 
the Foxp3 promoter and an enhancer was unaffected and the consequence of this 
binding on transcription was never evaluated (Samon et al., 2008). In contrast to these 
two reports, multiple in vivo studies have found that inhibition of Notch signaling results 
in increased Treg differentiation. In models of graft-versus-host disease (GvHD) and 
experimental autoimmune encephalomyelitis (EAE), inhibition of Notch signaling 
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ameliorates disease and results in decreased inflammatory T cell differentiation coupled 
with enhanced Treg differentiation (Bassil et al., 2011; Sandy et al., 2013; Tran et al., 
2013; Zhang et al., 2011). Not only do this disease models highlight a role for Notch in 
antagonizing Treg differentiation, but the observation that there are no steady-state 
developmental or inflammatory defects in mice with a conditional loss of Notch signaling 
in peripheral T cells suggests that Notch cannot be an essential positive regulator of 
Treg differentiation (Amsen et al., 2007; Amsen et al., 2004; Tu et al., 2005). Chapter 3 
will discuss new findings indicating that Notch signaling acts to destabilize Treg 
differentiation, with data from CD4-cre x ICN1FL/FL mice showing that activation of Notch 
in T cells leads to lethal autoinflammation, consistent with a negative regulatory role for 
Notch in Treg differentiation. 
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CHAPTER 2: Notch simultaneously orchestrates multiple helper T cell programs 
independently of cytokine signals 
Abstract 
Two models are proposed to explain Notch function during helper T (Th) cell 
differentiation. One argues that Notch instructs one Th cell fate over the other, whereas 
the other posits that Notch function is dictated by cytokines. Here we provide a detailed 
mechanistic study investigating the role of Notch in orchestrating Th cell differentiation. 
Notch neither instructed Th cell differentiation nor did cytokines direct Notch activity, but 
instead, Notch simultaneously regulated the Th1, Th2, and Th17 cell genetic programs 
independently of cytokine signals. In addition to regulating these programs in both 
polarized and non-polarized Th cells, we identified Ifng as a direct Notch target. Notch 
bound the Ifng CNS-22 enhancer, where it synergized with Tbet at the promoter. Thus, 
Notch acts as an unbiased amplifier of Th cell differentiation. Our data provide a 
paradigm for Notch in hematopoiesis, with Notch simultaneously orchestrating multiple 
lineage programs, rather than restricting alternate outcomes. 
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Introduction 
The T helper cell program adopted by a naïve CD4+ T cell is instructed both by 
extracellular molecules, such as cytokines, and intracellular molecules, such as the Th1, 
Th2, and Th17 cell transcription factors, Tbet, Gata3, and Rorγt respectively. Notch has 
also been proposed to mediate Th cell differentiation, where it functions to relay 
intercellular signals from the membrane to the nucleus in order to instruct Th cell 
differentiation (Amsen et al., 2009).  
As reviewed in Chapter 1, compelling cases have been made for Notch involvement in 
both Th1 and Th2 cell differentiation. Manipulating Notch ligand mediated stimulation of 
CD4+ T cells preferentially instructed Th1 or Th2 cell programs, suggesting that 
individual Notch ligands have different instructive capacities (Amsen et al., 2004; 
Maekawa et al., 2003; Okamoto et al., 2009). Loss of function studies also demonstrated 
that Notch instructed the Th1 cell program in vitro and promoted the CD4+ T cell IFNγ 
response in a murine GVHD model (Minter et al., 2005; Skokos and Nussenzweig, 2007; 
Zhang et al., 2011). In contrast, other reports showed that Notch was required to instruct 
the Th2 but not the Th1 cell program (Amsen et al., 2007; Amsen et al., 2004; Fang et 
al., 2007; Kubo, 2007; Tu et al., 2005). More recently, Notch was found to regulate the 
Th17 cell signature genes Il17a and Rorc, suggesting the bi-potential instructional model 
may not be sufficient to explain Notch function in Th cell differentiation (Keerthivasan et 
al., 2011; Mukherjee et al., 2009). While the instructional model posits that ligands direct 
Notch function during Th cell differentiation, an alternative model argues that Notch 
target gene selectivity is dictated by upstream cytokine signals (Ong et al., 2008). 
Despite the differences between these models, both contend that Notch has the capacity 
41 
 
to discriminately activate different Th cell programs. Thus, the paradox remains: how can 
such a basic signaling module selectively drive the differentiation of multiple distinct 
lineages? 
In order to address these controversies, we investigated the molecular mechanisms by 
which Notch orchestrates Th cell differentiation. We find that Notch neither initiates a 
single helper T cell program nor do cytokine signals dictate the outcome of Notch 
signaling. Instead, Notch simultaneously regulates the Th1, Th2, and Th17 genetic 
programs independently of cytokine signals. Even under strong polarizing conditions, 
Notch directly regulates critical effectors of Th1 Th2, and Th17 cell differentiation. In 
addition to Il4, Tbx21, Gata3-1a, Il17a, and Rorc, we identify Ifng as a direct Notch 
target. Notch regulates Ifng by binding to a highly conserved RBPJ motif in the Ifng 
CNS-22 and synergizes with Tbet activity at the Ifng promoter. These data support a 
model in which Notch integrates and amplifies cytokine-derived signals, instead of acting 
as a transcriptional driver or a downstream accessory of cytokines. Not only do our data 
unify the disparate data on Notch and Th cell differentiation but they also offer an 
alternative view of Notch function in the hematopoietic system, whereby Notch reinforces 
multiple fates rather than restricting alternate outcomes. 
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Results 
Notch signaling is dispensable for Th2  cell initiation during Trichuris muris infection. 
We previously showed that CD4+ T cells expressing the pan-Notch inhibitor dominant 
negative mastermind (DNMAML), which binds the Notch:RBPJ dimer but fails to 
transactivate, do not mount an effective Th2 cell response against the intestinal helminth 
Trichuris muris and fail to clear infection with normal kinetics (Tu et al., 2005). The 
outcome of T. muris infection depends on the balance of Th1 cells, which are 
responsible for chronic infection, and Th2 cells, which are required for parasite expulsion 
and resistance to infection (Artis et al., 2004; Blackwell and Else, 2001; Cliffe and 
Grencis, 2004; Cliffe et al., 2005; Else et al., 1994). While Notch was necessary for 
optimal Th2 cell-dependent immunity in this infection model, it remained unclear whether 
Notch was essential to initiate Th2 cell differentiation or instead, was required to 
generate the optimal balance of Th1 and Th2 cells. To test this, CD4-cre (CC) and CD4-
cre x DNMAMLFL/FL (CCD) mice were infected with T. muris and CCD mice were treated 
with neutralizing anti-IFNγ mAbs for the duration of infection. If Notch were required to 
initiate Th2 cell differentiation, anti-IFNγ treated CCD mice should remain susceptible to 
T. muris infection. Alternatively, if Notch played a greater role in generating an optimal 
Th2 cell response, then IFNγ blockade should be sufficient to relieve any inhibitory 
effects of a suboptimal Th1:Th2 ratio on infection-induced Th2 differentiation.  
As expected, mesenteric lymph node cells from the control CC mice displayed robust IL-
4, IL-5 and IL-13 responses upon restimulation (Figure 2-1A). Consistent with our 
previous findings, CCD mice demonstrated impaired Th2 cell cytokine responses (Figure 
2-1A). In contrast, CCD mice receiving anti-IFNγ mAb treatment restored IL-4, IL-5, and 
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IL-13 production and diminished IFNγ production, suggesting that Notch was not 
required to initiate Th2 responses (Figure 2-1A). In agreement with the cytokine data, 
CCD mice displayed an impaired protective T. muris specific IgG1 response and an 
elevated non-protective T. muris specific IgG2c response. In contrast, anti-IFNγ mAb 
treated CCD mice recovered parasite specific IgG1 and showed a trend towards 
decreased IgG2c (Figure 2-1B). Similarly, while CCD mice displayed decreased serum 
IgE, anti-IFNγ mAb treatment restored this response (Figure 2-1C). Furthermore, 
histologic analysis of intestinal sections revealed that anti-IFNγ mAb treatment rescued 
the goblet cell mucin response in CCD mice (Figure 2-1D). Finally, anti-IFNγ mAb 
treatment restored the ability of CCD mice to expel parasites with kinetics comparable to 
infected CC control mice by 21 days post infection (Figure 2-1E). Collectively, these data 
demonstrate that Notch is not essential to initiate Th2 cell responses in vivo, and instead 
suggest that Notch functions to optimize the response. 
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Figure 2-1: Notch signaling is dispensable for Th2 initiation during Trichuris 
muris infection. (A) At day 21, MLN from T. muris infected CC, CCD, and CCD + anti-
IFNγ mice were stimulated with anti-CD3 for 72 hours and cytokine levels were 
measured by ELISA. (B) Serum T. muris specific IgG1 and IgG2c and (C) total IgE 
were measured by ELISA from infected mice, at day 21. (D) Goblet cells in gut sections 
were detected by mucin staining. (E) Worm burden at day 21 post-infection. *, P < 0.05 
 
A. 
B. C. 
D. E. 
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Persistent Notch signaling is required to maintain the Th1 and Th2 cell programs. 
To further test whether Notch is required to maintain an optimal Th2 cell response, we 
investigated the effect of inhibiting Notch subsequent to Th2 cell differentiation. For 
these studies, we developed an in vitro differentiation system in which Notch could be 
inhibited at different times by addition of a gamma secretase inhibitor (GSI) following 
activation of CD4+ T cells. This system also provided the opportunity to test the 
requirement for Notch in Th1 cell differentiation. Importantly, Notch inhibition by GSI did 
not affect T cell activation, proliferation, or cell numbers, even after prolonged exposure 
(Figure 2-2A-C), in contrast to a recent report (Helbig et al., 2012). To look at Notch 
specific effects and exclude autocrine cytokine effects, cells were cultured in the 
presence of neutralizing IL-4 and IFNγ antibodies.  
To test whether Notch was required post-initiation to maintain both the Th1 and Th2 cell 
programs, naïve CD4+ T cells were activated in the presence of irradiated splenocytes. 
After 5 days, cells were restimulated and treated with either DMSO or GSI and left in 
culture for an additional 2 days (day 7) before harvest. When looking at Th1 cell 
signature genes, both mRNA and protein for Tbet and IFNγ were significantly lower after 
2 days of GSI treatment (Figure 2-3A-C). Similarly, GSI decreased mRNA and protein 
expression of the Th2 signature genes, Gata3 and Il4 (Figure 2-3A-C).  
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Figure 2-2: GSI treatment does not affect T cell activation. (WT naive CD4+ T cells 
were CFSE labeled and then stimulated with irradiated splenocytes (1:5), anti-CD3e (1 
µg/mL), and anti-CD-28 (1 µg/mL), cultured in media containing 5 ng/mL IL-2, 20 
µg/mL anti-IL-4, and 20 µg/mL anti-IFNγ and treated with either DMSO or 1 µM GSI. 
On day 5, cells were washed, restimulated, and cells previously cultured in DMSO were 
either replated in DMSO or 1 µM GSI, while cells previously cultured in GSI were 
maintained in GSI. (A) FACS analysis of cell proliferation on day 3 post-activation. (B) 
Cell numbers on days 3, 5, and 7 post-activation. (C) FACS analysis of CD69 
expression on cells days 5 and 7 post-activation. Data are represented as mean +/- 
SEM. Related to Figure 2. 
 
A. B. C. 
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Figure 2-3: Persistent Notch signaling is required to maintain the Th1 and Th2 
programs. (A) Schematic of experimental design. WT naive CD4+ T cells were 
stimulated with irradiated splenocytes, anti-CD3ε, and anti-CD28, and cultured under 
neutral conditions. After 5 days, cells were restimulated as above and replated in 
media containing either DMSO or 1 µM GSI. After 2 days (day 7 post-activation), (B) 
RNA was then harvested and analyzed by qPCR. Cells were analyzed for (C) cytokine 
production and (D) transcription factor expression by intracellular FACS.*, P < 0.05  
 
A. B. 
C. D. 
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While our data show that persistent Notch signaling is required to maintain the Th1 and 
Th2 cell programs post-initiation, it remained unclear whether the activity of Notch on 
Th1 and Th2 cell targets was restricted to early patterning events or if Notch was 
capable of re-activating target genes late after T cell stimulation. To address this, naïve 
CD4+ T cells were activated in the presence of either DMSO or GSI, under neutralizing 
conditions. After 5 days, cells were washed, restimulated, and returned to either DMSO 
or GSI to test whether cells previously treated with GSI could recover cytokine and 
transcription factor expression. While cells treated with GSI for all 7 days of culture 
showed impaired Tbet and IFNγ induction, cells treated with GSI only for the first round 
of stimulation recovered Tbet and IFNγ responses (Figure 2-4A-C). Similarly, IL-4 and 
GATA3 expression decreased when cells were treated with GSI for all 7 days and 
recovered when GSI was removed (Figure 2-4A-C). Our findings indicate that Notch is 
capable of promoting Th1 and Th2 signature gene expression both at early and late time 
points following stimulation and that inhibiting Notch at either the beginning of T cell 
stimulation or at later time points represses both Th1 and Th2 cell differentiation. 
Furthermore, we repeatedly observed that expression of both Th1 and Th2 cell program 
genes and proteins were suppressed in the same population upon Notch inhibition, 
suggesting that Notch concurrently regulates both programs. Collectively, these data 
show that Notch functions in Th cell differentiation do not require upstream signals from 
polarizing cytokines and demonstrate that the activity of Notch on its targets is not 
kinetically restricted. 
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Figure 2-4: The activity of Notch signaling during T cell differentiation is not 
restricted to early activation events. (A) Schematic of experimental design. WT 
naive CD4+ T cells were stimulated and cultured as above for 5 days in media 
containing either DMSO or GSI. Cells were then washed and restimulated under the 
same conditions, with cells previously cultured in DMSO being replated in media 
containing DMSO and cells previously treated with GSI being replated in either DMSO 
or 1 µM GSI. After 2 days of restimulation, (B) RNA was then harvested and analyzed 
by qPCR. Cells were analyzed for (C) cytokine production and (D) transcription factor 
expression by intracellular FACS. *, P < 0.05 
  
 
A. B. 
C. D. 
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Notch concurrently regulates both the Th1 and Th2 programs.  
Although both Th1 and Th2 cell signature genes were sensitive to GSI, it was important 
to show that the effects were Notch-specific as GSI has Notch-independent effects. 
Furthermore, Notch-independent, Presenilin-dependent effects on cytokine production 
were reported for both Th1 and Th2 cell types (Ong et al., 2008). To test whether the 
changes we observed were Notch-specific, we utilized mice containing two floxed alleles 
of dominant negative mastermind (DNMAMLFL/FL), a potent and specific GFP-tagged 
pan-Notch inhibitor.  
Tat-Cre treated YFPFL/FL and DNMAMLFL/FL naïve CD4+ T cells were stimulated under 
neutralizing conditions. Use of the Tat-Cre peptide to acutely induce DNMAML 
expression minimized potential compensation for Notch signaling by other pathways. As 
expected, YFP+ T cells produced IL-4 and IFNγ (Figure 2-5A). Consistent with 
observations using GSI treatment, DNMAML expressing T cells displayed a marked 
reduction in the fraction of cells that produced IL-4 and IFNγ confirming that Notch 
regulates both IL-4 and IFNγ production in the same cell population (Figure 2-5A). In 
contrast to the GSI data, analysis of Tbet and GATA3 protein in DNMAML expressing 
cells revealed reduced expression of Tbet, but not GATA3 (Figure 2-5B). Notch had 
been shown to regulate Tbx21 in a GSI-dependent manner and directly regulate Il4 via a 
3’ enhancer; however, the GATA3 result was unexpected as Notch directly regulates 
Gata3 transcription by binding to the Gata3-1a promoter in primary CD4+ T cells (Amsen 
et al., 2007; Amsen et al., 2004; Fang et al., 2007; Minter et al., 2005). When transcripts 
for both Th1 and Th2 signature genes were analyzed by qPCR, all four (Il4, Gata3-1a, 
Ifng and Tbx21) were expressed at lower levels in DNMAML expressing cells (Figure 2-
5C). The observed differences in GATA3 protein expression between GSI and DNMAML 
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treatment were likely due to the finding that GSI suppressed transcripts from both Gata3-
1a and Gata3-1b, whereas DNMAML only suppressed the Gata3-1a transcript, which 
accounts for a minor fraction of total Gata3 transcripts (Yu et al., 2009) (Figure 2-6A-B). 
These data indicate that Notch likely exerts its primary effect on the Th2 program 
through its regulation of Il4. It is important to note that while DNMAML expression had no 
impact on cell proliferation (Figure 2-6C), we did observe a minor increase in apoptosis 
as measured by Annexin-V (Figure 2-6D). While this subtle increase cannot account for 
the marked reduction in cytokine transcript and protein observed in DNMAML expressing 
cells, it suggests that a role for Notch signaling in cell survival may also contribute to 
these defects. 
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Figure 2-5: Notch signaling is required for the expression of both Th1 and Th2 
signature genes. YFPFL/FL or DNMAMLFL/FL CD4+ T cells were Tat-cre treated and 
rested for 24 hours in media containing 100 ng/mL IL-7. Naive CD4+ T cells were then 
FACS sorted and stimulated with irradiated splenocytes, anti-CD3ε, and anti-CD28, 
and cultured under neutral conditions. After 5 days, (A) cytokine production was 
measured by intracellular FACS, (B) Tbet and Gata3 protein was measured by 
intracellular FACS, and (C) RNA was analyzed by qPCR. *, P < 0.05 
  
 
C. 
A. B. 
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Figure 2-6: DNMAML expression does not affect Gata3-1b transcription or cell 
viability. (A) WT naive CD4+ T cells were CFSE labeled and then stimulated with 
irradiated splenocytes (1:5), anti-CD3e (1 µg/mL), and anti-CD-28 (1 µg/mL), cultured 
in media containing 5 ng/mL IL-2, 20 µg/mL anti-IL-4, and 20 µg/mL anti-IFNγ and 
treated with either DMSO or 1 µM GSI. RNA was harvested on day 5 post-activation 
and analyzed by qPCR. (B) YFPfl/fl or DNMAMLfl/fl CD4+ T cells were Tat-cre treated 
and rested for 24 hours in media containing 100 ng/mL IL-7. Naive CD4+ T cells were 
then FACS sorted and stimulated with irradiated splenocytes (1:5), anti-CD3e (1 
µg/mL), and anti-CD-28 (1 µg/mL), and cultured in media containing 5 ng/mL IL-2, 20 
µg/mL anti-IL-4, and 20 µg/mL anti-IFNg. After 5 days, RNA was harvested and 
analyzed by qPCR. (C) YFPFL/FL or DNMAMLFL/FL CD4+ T cells were Tat-cre treated and 
rested for 24 hours in media containing 100 ng/mL IL-7. Naive CD4+ T cells were then 
FACS sorted, labeled with CFSE, and stimulated as above under neutral conditions. 
After 3 days, cell proliferation was measured by FACS. (D) FACS sorted, Tat-cre 
treated, naïve CD4+ T cells from either YFPFL/FL or DNMAMLFL/FL mice were stimulated 
as above under neutral conditions. Apoptosis and cell death were measured on day 5 
by FACS using Annexin-V and DAPI staining.   
 
A. B. 
C. D. 
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Our observation that both Th1 and Th2 cell signature genes were sensitive to Notch 
inhibition in the same population suggested that Notch does not instruct one program 
over the other, but instead acts as a global regulator. This raised the possibility that 
Notch could influence both Th1 and Th2 cell signature genes, even in strongly polarizing 
conditions. In order to assay direct Notch effects, we utilized the GSI-washout assay 
(Weng et al., 2006). Notch targets are identified as transcripts that demonstrate GSI 
sensitivity under mock wash conditions and recover upon washout in the presence of 
cycloheximide. 
 
Naïve CD4+ T cells were activated as described and cultured under strong Th1 or Th2 
cell polarizing conditions. As published, both Il4 and Gata3-1a behaved as direct Notch 
targets under Th2 cell polarizing conditions (Amsen et al., 2007; Amsen et al., 2004; 
Fang et al., 2007) (Figure 2-7A). Unexpectedly, both of these genes behaved as direct 
Notch targets under Th1 cell polarizing conditions, although the magnitude of their 
expression was greatly reduced, likely due to suppression by Th1 cell culture conditions 
(Figure 2-7B). Consistent with others (Minter et al., 2005), we identified Tbx21 as a 
direct Notch target in Th1 cell conditioned cells, but surprisingly also observed that 
Tbx21 behaved as a direct Notch target even under Th2 cell polarizing conditions 
(Figure 2-7B). To confirm the unbiased behavior of Notch under polarizing conditions, 
chromatin immunoprecipitation (ChIP) assays were performed. Consistent with GSI-
washout results, Notch1 bound the previously reported Il4 HS5, Gata3-1a, and Tbx21 
Notch1 binding sites (Figure 2-7C). The magnitude of Notch binding was similar in both 
Th1 and Th2 cell polarizing conditions suggesting that the polarizing conditions do not 
bias Notch binding to these critical Th1 and Th2 cell targets. This is also show 
endogenous Notch1 binds Tbx21 in primary cells, confirming previous studies (Minter et 
al., 2005). Together with GSI-washout data, our ChIP findings confirm that Notch 
concurrently regulates both Th1 and Th2 programs, independent of cytokine signals. 
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Figure 2-7: Notch concurrently regulates both the Th1 and Th2 programs. (A) 
Schematic of experimental design for the GSI washout assay. WT CD4+ T cells were 
stimulated as above and cultured under either Th1 or Th2 culture conditions. After 24 
hours, cells were treated with either DMSO or GSI for 20 hours. Subsequently, T cells 
were CD4+ MACS purified and cells cultured in DMSO were replated in DMSO and 
cells cultured in GSI were either replated in GSI (Mock) or in DMSO (Washout) for 4 
hours; all cells were placed in media containing CHX. (B) RNA was then harvested and 
analyzed by qPCR. (C) WT CD4+ T cells were stimulated as above. After 2 days, cells 
were fixed and ChIP was performed using anti-Notch1 antibody, with Nanog serving as 
an internal negative control. As a negative control for the assay and antibody, anti-
Notch1 ChIP was performed on CD4-cre x Notch1FL/FL CD4+ T cells. *, P < 0.05  
 
A. B. 
C
. 
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Notch simultaneously orchestrates multiple Th cell programs by sensitizing cells to 
exogenous cytokine 
Having observed that Notch regulates both Th1 and Th2 cell programs, we hypothesized 
that Notch could regulate these targets in other Th cell populations, such as Th17 cells. 
To test this, naïve CD4+ T cells were activated as described, cultured under strong Th17 
cell differentiating conditions, and subjected to the GSI-washout assay. Consistent with 
Th1 and Th2 cell observations, Il4 and Tbx21 both behaved as direct Notch targets in 
Th17 polarized cells (Figure 2-8A); Gata3-1a transcript was undetectable under these 
conditions (data not shown). To test if Notch1 binding was conserved between Th1, Th2, 
and Th17 cells, ChIP analysis was performed. In keeping with our GSI washout 
observations, Notch1 bound to the Il4, Gata3-1a, and Tbx21 loci in Th17 polarized cells, 
demonstrating that even though Gata3-1a was expressed at levels below the limit of 
detection, Notch still occupied this region. These data illustrate that the concurrent 
regulation of Th cell programs by Notch is not a unique feature of Th1 and Th2 cells, but 
rather a conserved function of Notch signaling in mature, activated CD4+ T cells.  
To further demonstrate that Notch functions to regulate multiple cell programs from a 
common progenitor, we assayed whether the Th17 cell signature genes Il17a and Rorc 
behaved as direct Notch targets, regardless of the cytokine environment. Naïve CD4+ T 
cells were activated as described, cultured under Th1, Th2, or Th17 cell conditions, and 
subjected to the GSI washout assay. Although the expression varied by condition, Il17a 
and Rorc both behaved as direct Notch targets in all three Th cell types (Figure 2-8C).  
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Figure 2-8: Notch simultaneously orchestrates multiple Th cell programs. WT 
CD4+ T cells were stimulated as described under Th17 culture conditions. (A) After 24 
hours, cells were treated with either DMSO or GSI for 20 hours and then subjected to a 
GSI washout assay. Cells cultured in DMSO were replated in DMSO and cells cultured 
in GSI were either replated in GSI (Mock) or in DMSO (Washout) for 4 hrs. RNA was 
then harvested and analyzed by qPCR. (B) After 2 days, cells were fixed and ChIP was 
performed using anti-Notch1 antibody, with Nanog serving as an internal negative 
control. Anti-Notch1 ChIP was performed on CD4-cre x Notch1FL/FL CD4+ T cells as an 
experimental and antibody negative control. (C) A GSI washout assay was performed 
as above on activated CD4+ T cells cultured under either Th1, Th2, or Th17 polarizing 
conditions. At the end of the assay (48 hrs), RNA was harvested and analyzed by 
qPCR. (D) Naive CD4+ T cells were FACS sorted from Tat-Cre treated YFPFL/FL or 
DNMAMLFL/FL CD4+ T cells. Cells were then stimulated as above, and cultured under 
Th17 conditions. After 3 days, cytokine production was measured by intracellular 
FACS. (E) WT CD4+ T cells were stimulated as described and then cultured in a 
titration series of two-fold serially diluted Th1, Th2, or Th17 conditioned media, in the 
presence of either DMSO or GSI. After 5 days, cells were restimulated and 
supernatants were analyzed by ELISA two days later. *, P < 0.05 
 
A. B. C. 
D. E. 
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To confirm that the observed effects on Th17 celll signature gene transcription were 
biologically significant, we expressed DNMAML in naïve CD4+ T cells using Tat-Cre, as 
described, and activated them under Th17 differentiating conditions. We observed at day 
3 that DNMAML expression resulted in a marked reduction in the frequency of IL-17A 
producing cells (Figure 2-8D).  
 
In light of reports showing that exogenous cytokine has the capacity to rescue cytokine 
production in Notch loss of function models (Amsen et al., 2004; Tu et al., 2005), we 
hypothesized that an important function of Notch was to sensitize CD4+ T cells to 
polarizing factors, especially when these factors may be limiting. To test this, CD4+ T 
cells were activated in the presence of serially diluted Th1, Th2, or Th17 polarizing 
cytokines, with media containing either DMSO or GSI. If Notch played a role in 
sensitizing cells to exogenous cytokine, we would predict that Notch inhibition would 
minimally affect differentiation at high levels of differentiating factors, but exert a 
negative effect on differentiation when exogenous cytokines were diluted.  When cells 
were cultured in the presence of DMSO, secretion of IFNγ, IL-4, and IL-17A displayed an 
expected dose dependent response to polarizing cytokine, with maximal cytokine 
secretion observed in undiluted differentiating media (Figure 2-8E). Consistent with our 
hypothesis, when cells were cultured with GSI, cells displayed similar levels of cytokine 
secretion to DMSO control cells when differentiating cytokine was undiluted, but a much 
more rapid and marked decay in cytokine secretion when differentiating factors became 
limiting (Figure 2-8E). Altogether, these findings demonstrate that Notch simultaneously 
orchestrates multiple Th cell programs by sensitizing cells to exogenous differentiating 
factors. 
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Notch directly regulates IFNγ expression, independently of Tbet. 
As Notch regulates a Gata3:Il4 axis in Th2 cells and an Il17a:Rorc axis in Th17 cells, we 
hypothesized that Notch might similarly regulate a Tbx21:Ifng axis in Th1 cells. To 
confirm that Ifng is a direct Notch target, we performed a GSI washout assay on cells 
cultured under strong Th1, Th2, and Th17 polarizing conditions. Similar to Gata3-1a, Il4, 
and Tbx21, Ifng behaved like a direct Notch target under all three culture conditions 
(Figure 2-9A).  
To exclude the possibility that effects of Notch on Ifng resulted from indirect effects on 
Tbx21, we inhibited Notch signaling in Tbx21-/- cells. Naïve CD4+ T cells from WT and 
Tbx21-/- mice were activated and retrovirally transduced with vector control (MigR1) or 
DNMAML. To obtain sufficient IFNγ expression in Tbet deficient cells, cells were cultured 
in the presence of IL-12 and neutralizing anti-IFNγ and anti-IL-4 antibodies, conditions 
that allow Tbet-independent IFNγ production (Schulz et al., 2009; Usui et al., 2006) and 
exclude confounding paracrine effects between transduced and untransduced cells. 
Transduction of either WT or Tbx21-/- cells with DNMAML decreased the fraction of cells 
producing IFNγ as well as the total amount of IFNγ secreted (Figure 2-9B-C). 
Collectively, these data suggest that Notch directly regulates Ifng expression, 
independently of its role in regulating Tbx21, and identify Ifng as a Notch target. 
60 
 
 
 
 
 
Figure 2-9: Notch directly regulates Ifng expression. (A) WT CD4+ T cells were 
stimulated as described under either Th1, Th2, or Th17 culture conditions. 24 hours 
later, cells were treated with either DMSO or GSI for 20 hours and then subjected to a 
GSI washout assay. Cells cultured in DMSO were replated in DMSO and cells cultured 
in GSI were either replated in GSI (Mock) or in DMSO (Washout) for 4 hours. RNA was 
then harvested and analyzed by qPCR. (B) Schematic of experimental design. WT and 
Tbet KO naive CD4+ T cells were stimulated as above and cultured with IL-12 (5 
ng/mL), anti-IL-4 (20 µg/mL), and anti-IFNγ (20 µg/mL). After 24 hours, cells were 
retrovirally transduced with either vector control (Mig) or DNMAML. (C) Cytokine 
production was measured by intracellular FACS and (D) cytokine secretion by ELISA, 
48 hours post-transduction. *, P < 0.05 
 
A. B. 
C. 
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Notch1 binds to the Ifng CNS-22 
To determine the mechanism by which Notch directly regulates Ifng, we searched for 
RBPJ binding sites in regions known to be critical for Ifng transcription (Hatton et al., 
2006). Three RBPJ elements were identified in the Ifng CNS-22, a conserved enhancer 
that is required for Ifng expression in T and NK cells (Figure 2-10A) (Hatton et al., 2006). 
Primers were designed for ChIP that flanked the strongest and most conserved RBPJ 
binding site in the region. Two days after stimulation, CD4+ T cells exhibited Notch1 
binding at the Ifng CNS-22 (Figure 2-10B). Similar to Il4, Gata3-1a, and Tbx21 (Figure 
3F), Notch1 bound the Ifng CNS-22 site in Th1, Th2, and Th17 cells (Figure 2-10B).  
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Figure 2-10: Notch binds to the Ifng CNS-22. (A) Multiple species alignment of the 
Ifng CNS-22 region, using NCBI DCODE.org. Highly conserved strong (red), moderate 
(orange), and weak (yellow) RBPJ binding sites are highlighted. Primer sequences 
used for ChIP are underlined. (B) WT CD4+ T cells were stimulated as described and 
cultured under Th1, Th2, or Th17 conditions. After 2 days cells were fixed and ChIP 
was performed using anti-Notch1 antibody, with Nanog serving as an internal negative 
control. Anti-Notch1 ChIP on CD4-cre x Notch1FL/FL CD4+ T cells served as a negative 
control for the antibody and assay.  
A. 
B. 
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Notch1 and Tbet synergize to drive transcription from the Ifng CNS-22 
The observation that Notch1 binds the Ifng CNS-22 suggested that Notch directly 
regulates Ifng expression through this element. To test this, we utilized reporter 
constructs for the Ifng CNS-22 region (Hatton et al., 2006). These constructs contain 
either the minimal 468 bp Ifng promoter (ProWT) or this promoter with the Ifng CNS-22 
placed upstream (CNSWTProWT). Two putative T-box half-sites were identified in the Ifng 
CNS-22 fragment and mutant constructs were generated to both the upstream 
(CNSMT1ProWT) and downstream (CNSMT2ProWT) T-box half-sites (Figure 2-11A) (Hatton 
et al., 2006). Although the CNSMT2ProWT construct was originally described as a Tbet 
binding site mutant, this same mutation also ablates the most highly conserved RBPJ 
binding site in Ifng CNS-22. To test if Notch was capable of driving transcription through 
the Ifng CNS-22 at this site in cells capable of endogenous IFNγ production, activated 
Jurkat cells were transfected with vector control (pcDNA) or the constitutively active 
Notch1 intracellular domain ICN1 (Aster et al., 2000), as well as a reporter containing 
pGL3, ProWT, CNSWTProWT, or CNSMT2ProWT (Figure 2-11B). Addition of CNSWTProWT 
resulted in slightly increased reporter activity that was markedly enhanced upon the 
addition of ICN1, suggesting that Notch has the capacity to act on this enhancer 
element. When CNSMT2ProWT was used, the increased activity observed from the 
CNSWTProWT was lost and the addition of ICN1 failed to enhance reporter activity (Figure 
2-11B). These data suggest that Notch1 is capable of enhancing transcription through 
the Ifng CNS-22. 
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Figure 2-11: Notch1 and Tbet synergize to drive transcription from the Ifng CNS-
22. (A) Schematic of the luciferase constructs used, as detailed in the methods. (B) 2 X 
105 Jurkat cells were transfected with renilla control (pRLTK), either the ProWT, 
ProWTCNSWT, or ProWTCNSMT2 luciferase reporter constructs, and either a vector 
control or ICN1, using DMRIE-C liposomes. After 20 hours, cells were stimulated with 
PMA and ionomycin for 4 hours. Cells were then washed and luciferase activity was 
measured. (C) 2 X 104 U2OS cells were transfected with pRLTK, either the promoter 
ProWT, ProWTCNSWT, ProWTCNSMT1, or ProWTCNSMT2 reporter constructs, ICN1 or vector 
control, and Tbet or vector control. After 48 hours, luciferase activity was measured. 
(D) 2 X 104 U2OS cells were transfected with pRLTK, either the ProWT, ProMT, 
ProWTCNSWT, or ProMTCNSWT reporter constructs, ICN1 or vector control, and Tbet or 
vector control. After 48 hrs, luciferase activity was measured. *, P < 0.05 
 
A. B. 
C. D. 
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Although the Jurkat cell data established that Notch1 can drive transcription from the 
Ifng CNS-22 in a mature T cell line, it remained possible that Notch1 indirectly enhanced 
luciferase activity by promoting Tbx21 transcription. In addition, the loss of luciferase 
activity observed when CNSMT2ProWT was expressed may have resulted from a loss of 
Tbet binding, rather than the loss of RBPJ binding at the same site. To test these 
alternate hypotheses, we utilized U2OS cells, which do not express endogenous Tbx21 
and express very low amounts of Notch1 (data not shown). U2OS cells were transfected 
with the reporter constructs described above as well as CNSMT1ProWT , which ablates the 
upstream T-box half-site without disrupting the RBPJ binding site. Tbet overexpression 
in U2OS cells increased luciferase activity in all constructs (Figure 2-11C). This effect 
appeared primarily due to Tbet activity on the Ifng minimal promoter, as the addition of 
the Ifng CNS-22 and mutation of either T-box half-site had no additional effect on 
reporter activity (Figure 2-11C). 
 
In contrast to Jurkat cells, ICN1 did not increase luciferase activity in U2OS cells, 
suggesting that other factors endogenous to Jurkat cells, such as Tbet, may be required 
to cooperate with Notch1 activity. Accordingly, co-expression of Tbet and ICN1 
synergistically increased, luciferase activity from CNSWTProWT. Moreover, the enhanced 
luciferase activity was specific to CNSWTProWT and was not observed with ProWT, 
suggesting that the synergy between Notch1 and Tbet resulted from Notch1 activity at 
the Ifng CNS-22 (Figure 2-11C).  
To directly address this possibility, we utilized the construct in which the upstream T-box 
half-site was mutated (CNSMT1ProWT). In cells expressing this reporter, luciferase activity 
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was similar to the CNSWTProWT under all conditions, suggesting that the primary effect of 
Tbet was through its activity on the promoter. In contrast, when the conserved RBPJ 
binding site was mutated (CNSMT2ProWT), luciferase activity was comparable to the ProWT 
construct (Figure 2-11C). Collectively, these data suggest that ICN1 acts at the Ifng 
CNS-22 enhancer and Tbet acts at the Ifng promoter.  
To directly assay the site of Tbet activity, we mutated the T-box site in the Ifng promoter 
leaving the putative Tbox sites in the CNS-22 intact (Tong et al., 2005) (Figure 2-11A). 
When U2OS cells were transfected with ProMT, neither Tbet alone nor Tbet plus ICN 
increased reporter activity to that observed in ProWT (Figure 2-11D). Moreover, mutation 
of the promoter in the context of CNS-22 (CNSWTProMT) ablated the ability of either Tbet 
alone or Tbet plus ICN1 to increase reporter activity (Figure 2-11D). Overall, these data 
demonstrate that binding of Notch at the Ifng CNS-22 is insufficient to activate 
transcription by itself and that Tbet binding at the promoter leads to weak activation; 
however, the combination of Notch binding to the CNS-22 and Tbet binding to the Ifng 
promoter leads to a synergistic increase in Ifng transcription.  
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Discussion 
Within the lymphoid compartment, Notch is understood to selectively promote one 
lineage outcome at the expense of alternate fates (Radtke et al., 2010). This instructive 
paradigm was proposed to explain Th cell differentiation, however, the emerging data 
are difficult to reconcile with this model as Notch promotes mutually exclusive cell fates 
from a multipotential cell (Amsen et al., 2004; Maekawa et al., 2003; Minter et al., 2005; 
Mukherjee et al., 2009; Tu et al., 2005). Here, we present data demonstrating that Notch 
acts as an unbiased amplifier of the Th1, Th2, and Th17 cell programs by sensitizing 
cells to environmental signals.  
By acutely inhibiting Notch signaling under neutralizing conditions, we reveal a role for 
Notch in simultaneously orchestrating both Th1 and Th2 programs. GSI treatment and 
acute DNMAML expression synchronously reduced IL-4, IFNγ, and Tbet protein and 
mRNA for Il4, Ifng, Tbx21, and Gata3-1a, demonstrating that Notch lacks selectivity in 
regulating critical Th cell program targets. We further observed that Notch regulates 
Th17 target genes even when their expression is suppressed under Th1 and Th2 
conditions and vice versa. Although the polarizing conditions influence the magnitude of 
gene expression, the ability of Notch to bind these key loci was unchanged, illustrating 
that the cytokine environment does not impact the ability of Notch to regulate its targets. 
Accordingly, our work suggests that Notch plays a critical role in reinforcing Th cell 
differentiation at physiologic levels of cytokine signaling, which would be important early 
during immune responses when differentiating cytokine cues are limiting. In addition, 
these findings help reconcile conflicting reports in the literature that emphasized the 
ability of Notch to preferentially regulate specific Th programs.  
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In related work, Ong et al. contended that Notch signaling itself had minimal impact on 
Th differentiation, but rather upstream cytokine signals directed Notch to selectivity 
enhance individual Th responses (Ong et al., 2008). Consistent with our findings, these 
studies argued that Notch lacks instructive capacity. Our T. muris studies provide the 
first in vivo loss-of-function data confirming that Notch is not required for instruction, 
however our GSI-washout and ChIP data provide a distinct mechanistic view of Notch 
function during Th differentiation. Rather than requiring cytokine signals to condition 
Notch selectivity, we find that Notch binds and regulates target loci without regard to 
cytokine signals. Moreover, we further show that Notch concurrently regulates Th cell 
programs even under neutralizing conditions. Thus, our work suggests that the activity of 
Notch is not dictated by cytokine signaling, but rather that Notch simultaneously 
facilitates transcription of multiple programs regardless of polarizing cues. 
In addition to providing a unifying model for Notch in Th cell differentiation, we present 
definitive genetic loss-of-function and molecular data evincing a role for Notch in the Th1 
program. Not only do our data demonstrate for the first time that endogenous Notch1 
binds Tbx21 and that Tbx21 is a direct Notch target in primary CD4+ T cells, but we also 
show that Ifng is a novel, direct Notch target, independent of Notch’s role in regulating 
Tbx21. While the Notch effects on Ifng are independent of its activity on Tbx21, Notch 
does not appear capable of driving Ifng transcription by itself, consistent with a model in 
which Notch lacks the capacity to instruct Th differentiation. Both factors are needed for 
optimal Ifng expression, where they bind different regulatory elements. Moreover, the 
Tbx21-/- studies suggest that Notch is capable of collaborating with factors other than 
Tbet, as DNMAML suppressed Ifng expression in its absence. The original report using 
these luciferase constructs found that Tbet overexpression was capable of enhancing 
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luciferase activity of the WT CNS-22 construct when cells were stimulated with PMA and 
ionomycin (Hatton et al., 2006), which also induces NFκB binding to the Ifng CNS-22 
(Balasubramani et al., 2010). As the Ifng CNS-22 contains multiple regulatory motifs, 
these data suggest that Tbet activity at the Ifng promoter synergizes with multiple factors 
regulating the Ifng CNS-22, including Notch and NFκB. Altogether, these data illustrate 
the dynamism of the Ifng promoter and CNS-22 and demonstrate how these elements 
have the potential to integrate inputs from multiple pathways. 
The results of our reporter assays are reminiscent of the synergy between Gata3 and 
Notch1 at the Il4 locus and suggest that Notch and cytokine signaling collaborate in both 
Th1 and Th2 differentiation (Fang et al., 2007). Furthermore, Notch appears to 
participate in a feed-forward loop, promoting Tbx21 transcription and in turn synergizing 
with Tbet protein to enhance Ifng transcription. Work by Flavell and colleagues suggests 
that this Th1 feed-forward loop must be stabilized by other factors (Amsen et al., 2007). 
In their study, constitutive Notch signaling was insufficient to enforce Th1 differentiation 
in the presence of endogenous Gata3, demonstrating that low levels of Gata3 act as a 
failsafe against runaway Th1 differentiation in response to Notch activation. In addition to 
transcriptional regulation, Notch can regulate IFNγ secretion in an RBPJ-independent 
manner, suggesting that Notch regulates the CD4+ T cell IFNγ response at multiple, 
mechanistically distinct levels (Auderset et al., 2012). Additionally, a recent human T cell 
study implicated a role for Notch in Th1 differentiation (Le Friec et al., 2012). Together, 
these data firmly establish Notch as a key regulator of the Th1 program.  
As well as revealing a definitive role for Notch in promoting Th1 differentiation, our data 
further clarify the mechanism by which Notch regulates Th2 differentiation. The findings 
from anti-IFNγ mAb treated T muris infected CCD mice indicate that the role of Notch 
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during in vivo Th2 inflammation is similar to what has been reported for NFκB2, IL-25, 
and TSLP (Artis et al., 2002; Owyang et al., 2006; Taylor et al., 2009). Like Notch, mice 
deficient for each of these factors displayed susceptibility to helminth infection and 
impaired Th2 immune responses, however blockade of Th1 responses in these mouse 
models resulted in restoration of the Th2 response and worm expulsion. Moreover, 
unlike the role for Notch in regulating Th1 differentiation, we observe a major role for 
Notch in promoting IL-4 production but minimal impact on total Gata3, suggesting that 
additional factors, such the Notch target Tcf1, may be required to fully engage the Th2 
program (Yu et al., 2009). These studies collectively illustrate a clear distinction between 
Th2 initiating factors, such as NFκB1 (Artis et al., 2002), and the multiple inputs that 
maintain an optimal Th2 response in vivo, but are dispensable for Th2 program initiation, 
such as Notch.  
In addition to regulating Notch-dependent IL-4 production in Th2 cells, recent work 
demonstrated that the IL-4 HS5 region is critical for T follicular helper cell (Tfh) 
production of IL-4 (Harada et al., 2012; Vijayanand et al., 2012). These findings raise 
the possibility that Notch inhibition in the T. muris studies may impact both Th2 and Tfh 
subsets during infection and the combined effects on these two populations contribute to 
the phenotype observed. Importantly, anti-IFNγ treatment restored productive immunity 
against helminth infection; and therefore, the role that Notch signaling plays in Tfh 
biology is either redundant with its function in Th2 cells or not essential for Tfh 
differentiation, similar to what we observe for Th1, Th2, and Th17 subsets.  
With the recent recognition of Th cell plasticity, particularly at early time points, our data 
suggest that Notch functions to ensure that activated CD4+ T cells overcome a Th cell 
commitment threshold (Murphy and Stockinger, 2010). In this manner, Notch tunes the 
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responsiveness of an activated CD4+ T cell to a specific Th cell program by sensitizing 
cells to limiting environmental differentiation cues. Thus, depending on the inflammatory 
environment for a given immune response, the requirement for Notch will vary 
depending on whether the strength of the differentiating signals a T cell receives are 
sufficient to achieve a signaling threshold for Th cell commitment. For example, during T. 
muris infection, our model argues that Notch sensitizes T cells to limiting Th2 
differentiating cues, while residual IFNγ signals destabilize the Th2 circuitry when Notch 
signaling is abrogated. This model would also explain why Th1 differentiation occurs 
independently of Notch during Leishmania infection, as we would predict that the 
environmental differentiating signals are sufficient to overcome a commitment threshold 
(Amsen et al., 2004; Tu et al., 2005). Alternatively, in the context of GvHD, which is 
characterized by a mixed Th cell response, Notch is required to sensitize cells to 
subthreshold signals and achieve optimal IFNγ production (Zhang et al., 2011). While 
our data favor a model in which Notch regulates Th differentiation by sensitizing cells to 
their environment, Notch likely plays additional roles in other aspects of Th biology, such 
as survival and metabolism, that warrant future study. 
Overall, these findings offer a paradigm for Notch in the immune system. In addition to 
its roles as an arbiter of alternate fate decisions and a key regulator of cell survival, 
proliferation, and metabolism, we reveal that Notch also acts to potentiate multiple fates 
from a single progenitor. Not only does this paradigm reconcile previously conflicting 
studies, but it also suggests that manipulating the amounts of Notch signaling in Th cell 
mediated pathologies may have therapeutic benefit. 
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CHAPTER 3: Notch signaling lacks instructional or oncogenic activity post-β-
selection 
 
Abstract 
Notch signaling is classically understood to instruct cell fates during development and to 
drive oncogenesis when hyperactivated during hematopoiesis. Enforced activation of 
Notch signaling in bone marrow progenitors or T lineage precursors prior to the β-
selection checkpoint instructs T lineage development and drives T cell acute 
lymphoblastic leukemia. Here we find that activation of Notch signaling after β-selection 
fails to instruct cell fates and does not promote leukemia. Instead, mice develop a lethal 
autoinflammatory disorder. This disease results from the ability of Notch signaling to 
concurrently promote Th1, Th2, and Th17 cell differentiation. Moreover, this study 
reveals a novel role for Notch signaling in destabilizing Treg differentiation. Notch 
signaling acts to desensitize T cells to TGFβ, such that inhibiting Notch signaling 
promotes Treg differentiation in non-permissive conditions. Notch’s dual role in 
promoting inflammatory Th cell differentiation and destabilizing Treg differentiation 
makes it a key regulator of the Th9-Treg and Th17-Treg axes and an attractive 
therapeutic target for inflammatory disorders. Altogether these findings highlight a loss in 
oncogenic potential for Notch signaling after β-selection and evince a non-instructional 
paradigm for Notch signaling in late-stage T lineage development . 
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Introduction 
Chapter 2 presented work showing that the Notch pathway has the capacity to sensitize 
activated CD4+ T cells, in an unbiased fashion, to environmental differentiation signals 
that promote inflammatory Th cell programs(Bailis et al., 2013). In this manner, Notch 
signaling is required for Th cell mediated inflammation in the context of diseases that are 
characterized by mixed-cytokine responses, such as Trichurus muris infection or graft-
versus-host disease, but is not essential for diseases characterized by the efficient and 
dominant differentiation of a single Th cell response, such as Listeria major(Tu et al., 
2005; Zhang et al., 2011). Unlike obligate factors, such as cytokines and co-stimulatory 
receptors, that have the capacity to instruct a given program and/or activate CD4+ T 
cells, these findings place Notch receptors in a unique category of auxiliary factors that 
act to boost local activating and differentiating cues in a nondiscriminatory manner.  
 
In contrast to its unbiased role in Th cell differentiation, Notch signaling is classically 
understood to play an essential function in instructing cell fate decisions(Radtke et al., 
2013). Within the hematopoietic compartment, Notch signaling is best known for its role 
in instructing T lineage development at the expense of B cells. To this end, enforced 
activation of the Notch pathway has been shown to potently drive T lineage commitment 
when the constitutively active intracellular Notch (ICN) domain is expressed in 
hematopoietic and early-T progenitors(Radtke et al., 2013). Moreover, high levels of 
sustained Notch signaling drive an oncogenic program that leads to the onset of T cell 
acute lymphoblastic leukemia (T-ALL)(Aster et al., 2011). In the peripheral T cell 
compartment, expression of ICN has been reported to selectively drive Th1 and Th2 cell 
differentiation(Amsen et al., 2007; Fang et al., 2007; Maekawa et al., 2003; Minter et al., 
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2005). Thus it remains possible that the Notch pathway behaves instructionally and/or 
signaling outcome is dictated by signal dose: such that at limiting concentrations, Notch 
acts in an unbiased manner, whereas above a certain threshold, the Notch pathway 
displays its classical instructional activity.  
 
In order to substantiate our loss-of-function in vitro findings and test whether the 
outcome of Notch signaling is merely dictated by signal dose, we bred CD4-Cre mice to 
mice homozygous for a flox-stopped ICN allele (ICNF/F), such that the Notch pathway is 
constitutively active in all T-lineage cells from the double positive (DP) stage of 
thymocyte development onward. All previous gain-of-function Notch studies have been 
performed using bone marrow progenitors or conditional models that induce Notch 
activation before the β-selection checkpoint of thymocyte development. In these models, 
activation of the Notch pathway instructs T cell development and drives T-ALL 
onset(Allman et al., 2001; Bellavia et al., 2000; Bellavia et al., 2002; Deftos et al., 2000; 
Pear et al., 1996; Pui et al., 1999; Robey et al., 1996). If Notch signal dose determines 
whether the Notch pathway behaves instructionally, then expression of ICN in DP 
thymocytes should lead to either T-ALL onset, the selective induction of a single Th cell 
program, or both. If Notch signaling acts by fundamentally distinct mechanisms in early 
and late T-lineage development, then the unbiased activity of Notch observed in our 
loss-of-function studies should manifest itself in these mice. 
 
Unlike previously reported gain-of-function Notch signaling models in early T-lineage 
progenitors, activation of the Notch pathway after β-selection does not lead to T-ALL 
onset. In contrast, CD4-Cre x ICNF/F (NIC) mice succumb to a lethal autoinflammatory 
disorder, mediated by CD4+ T cells and characterized by skin necrosis, multi-organ 
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inflammation, and wasting. Rather than promoting the differentiation of a single Th cell 
program, persistent Notch signaling simultaneously promotes the differentiation of Th1, 
Th2, and Th17 cells, in keeping with loss-of-function findings. Furthermore, these studies 
reveal a novel role for Notch signaling in destabilizing regulatory T (Treg) cell 
differentiation by desensitizing activated CD4+ T cells to TGFβ-derived signals, making 
Notch a key regulator of the Th17-Treg and Th9-Treg axes and an attractive therapeutic 
target for diseases resulting from CD4+ T cell-mediated inflammation. Altogether, these 
findings support a model in which the Notch pathway exerts distinct mechanistic 
functions in early and late in T cell development.   
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Results 
Enforced Notch signaling post-β-selection induces a lethal autoinfllammatory disorder, 
while failing to drive T-ALL 
To test the consequences of constitutive Notch signaling in post β-selection T cells, we 
bred CD4-Cre mice to ICN1FL/FL mice (Figure 1A), which maintains Notch signaling in T 
cells after β-selection. In contrast to models in which ICN1 is expressed before β-
selection, CD4--ICN1 mice fail to develop T-ALL. Instead, these mice die by 200 days of 
age from a disease process characterized by a severe systemic autoinflammatory 
disorder (Figure 3-1B). CD4-cre x ICN1 mice display severe skin necrosis, colitis, and 
cachexia (Figures 3-1C-D). Additionally, these mice exhibit hepatosplenomegaly and 
small thymi (Figures 3-1E-F). Histopathologic analysis revealed extensive granulocytic 
infiltrates in the  colon, liver, spleen, lymph nodes, and bone marrow (Figure 3-2A). 
Furthermore, these granulocytic infiltrates disrupted the normal tissue architecture 
(Figures 3-2B-C). Altogether, these data suggest that persistent Notch signaling post-β-
selection induces a lethal, autoinflammatory disorder.  
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Figure 3-1: CD4-Cre x ICN1FL/FL mice develop a lethal autoinflammatory disease. 
(A) Schematic of transgenic alleles for CD4-Cre and ICNFL/FL mice. (B) Kaplan-Myer 
survival curve of CD4-Cre and CD4-Cre x ICNFL/FL mice. (C) Representative picture of 
CD4-Cre x ICNFL/FL mice.  (D) Body weight, (E) spleen weight, and (F) thymus weight of 
CD4-Cre and CD4-Cre x ICNFL/FL mice. 
A. 
B. C. 
D. E. F. 
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Figure 3-2: CD4-Cre x ICN1FL/FL mice display severe neutrophilia and granulocyte 
infiltration (A) Flow cytometry of neutrophils in spleen, lymph node, and bone marrow 
of CD4-Cre and CD4-Cre x ICNFL/FL mice. (B) Histology of liver and colon sections from 
CD4-Cre and CD4-Cre x ICNFL/FL mice with H&E staining.  
A. 
B. 
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Helper T cells are responsible for mediating the autoinflammation observed in CD4-Cre 
x ICN1 mice 
Although CD4-Cre activates Notch signaling in post β-selection T cells, it remained 
possible that the disease observed originated from indirect affects on non-T lineage 
populations. To confirm that the autoinflammatory phenotype was due to Notch signaling 
within the T cell compartment, 1 x 106 purified T cells or T-depleted splenoyctes from 
either CD4-Cre x YFPFL/FL or ICN1 mice were adoptively transferred into WT mice. 
Granulocyte frequency was tracked as a biomarker for disease and three weeks post-
transplant, we assessed neutrophil content in the spleens of recipient mice. Even though 
the adoptively transferred cells were only a small fraction of circulating leukocytes in the 
WT recipient mice, T cells from CD4-Cre x ICN1 mice were sufficient to induce 
increased neutrophil recruitment, whereas CD4-Cre x YFPFL/FL T cells and non-T cells 
from either group failed to affect granulocyte frequency (Figure 3-3A). 
 
To further resolve the population of cells responsible for mediating the autoinflammation 
observed in CD4-Cre x ICN1mice, we tested the ability of CD4+ and CD8+ T cell subsets 
to of transfer disease. CD4+ or CD8+ T cells were FACS sorted from either CD4-Cre x 
YFPFL/FL or CD4-Cre x ICN1 mice and 1 x 106 cells were transferred to WT mice. After 
four weeks, granuloctye frequency was assessed in the spleens of recipient mice. While 
CD8+ T cells from both groups and CD4+ T cells from CD4-Cre x YFPFL/FL mice displayed 
normal levels of splenic granulocytes, CD4+ T cells from NIC mice were sufficient to 
induce granulocyte accumulation (Figure 3-3B). These data suggest that Th cells from 
CD4-Cre x ICN1 mice are the primary driver of disease. 
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Figure 3-3: CD4+ T cells mediate disease in CD4-Cre x ICN1FL/FL mice. (A)  T cells or 
T-depleted cells from CD4-Cre x YFPFL/FL or CD4-Cre x ICNFL/FL mice were adoptively 
transferred into WT mice. Neutrophil frequency in the spleens of recipient mice was 
analyzed by flow cytometry, three weeks post transfer. B6 mice were used as a normal 
control. (B) CD4+ and CD8+ T cells from CD4-Cre x YFPFL/FL or CD4-Cre x ICNFL/FL were 
adoptively transferred to WT mice. Neutrophil frequency in the spleens of recipient mice 
was analyzed by flow cytometry, four weeks post transfer.  
A. B. 
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Enforced Notch expression in peripheral T cells concurrently promotes Th1, Th2, and 
Th17 differentiation 
Having identified ICN1-expressing Th cells as the principal disease mediator, we sought 
to characterize the cytokine response of CD4-Cre x ICN1 CD4+ T cells. In contrast to 
previous reports that constitutive Notch1 signaling in hematopoietic progenitors or CD4+ 
T cells selectively instructs a single differentiation program(Amsen et al., 2007; Fang et 
al., 2007; Maekawa et al., 2003; Minter et al., 2005), our genetic model of enforced 
Notch signaling increased Th1, Th2, and Th17 differentiation (Figure 3A-B). Ex vivo 
stimulation of CD4-Cre x YFPFL/FL or CD4-Cre x ICN1 T cells with PMA and ionomycin 
revealed that CD4-Cre x ICN1 Th cells increased IL-4, IFNγ, and IL-17A production. 
Moreover, CD4-Cre x ICN1 Th cells spontaneously produced all three cytokines in the 
absence of stimulation, in contrast to control cells, indicating that Notch signaling 
concurrently promotes multiple inflammatory Th cell programs, findings that are 
consistent with loss-of-function findings(Bailis et al., 2013),. 
 
To verify that the increase in signature cytokine production of all three inflammatory Th 
subsets reflected bona fide Th cell differentiation and not an unstable, poly-activated 
state, we attempted to re-differentiate CD4-Cre x ICN1 T cells in vitro under Th1 or Th2 
conditions. If hyperactivation of Notch signaling resulted in a broad increase in cytokine 
production by T cells, but not true Th cell differentiation, then it should be possible to 
differentiate these cells to a single program under stringent Th1 or Th2 conditions. 
Additionally, if Notch signaling has any instructional bias toward a single program, it 
should revealed under these robust differentiating conditions. That is, if Notch has 
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instructional bias toward Th2 differentiation we should see synergy under Th2 conditions 
and retained IL-4 production under Th1 conditions, but not visa-versa. As expected, 
control T cells displayed a mixture of IL-4 and IFNγ production under non-differentiating 
Th0 conditions, only IFNγ production under Th1 conditions, and only IL-4 production 
under Th2 conditions (Figure 3C). In contrast, CD4-Cre x ICN1T cells display an 
increased capacity to produce both IL-4 and IFNγ under all three conditions (Figure 3C). 
Not only do CD4-Cre x ICN1 T cells retain IL-4 production under Th1 conditions and 
IFNγ under Th2 conditions, indicating that these are bona fide Th1 and Th2 differentiated 
cells, but these cells increased the IL-4, IFNγ double-producing population regardless of 
conditions, further supporting a role for Notch as an unbiased amplifier of multiple Th cell 
programs (Figure 3C). 
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Figure 3-4: CD4+ T cells from CD4-Cre x ICNFL/FL mice display spontaneous 
production of IL-4, IFNγ, and IL-17A. Lymph node cells from CD4-Cre or CD4-Cre x 
ICNFL/FL mice were either left unstimulated or activated with PMA and ionomycin for 5 hrs 
and then analyzed by intracellular flow cytometry for (A) IL-4 and IFNγ or (B) IL-17A. (C) 
CD4+ T cells from CD4-Cre or CD4-Cre x ICNFL/FL mice were stimulated with irradiated 
splenocytes, anti-CD3ε, and anti-CD28, and cultured under Th0, Th1, or Th2 conditions. 
After 5 days, cells were restimulated with PMA and ionomycin and analyzed by 
intracellular flow cytometry for IL-4 and IFNγ production. 
A. 
B. 
C
. 
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Notch signaling potentiates the differentiation of multiple inflammatory Th cell subsets in 
a cell-autonomous manner 
While our adoptive transfer studies indicate that small numbers of CD4-Cre x ICN1 T 
cells are sufficient to transfer hallmarks of the disease observed in CD4-Cre x ICN1 mice 
to WT recipients, it remained possible that the hyper-activation of these Th cells was 
secondary to Notch activation in another cell type or due to the absence of a normal T 
cell population. To address this, bone marrow cells from either SJL controls, CD4-Cre x 
ICN1 mice, or a 1:1 mix from SJL and NIC mice were transferred into lethally irradiated 
RAG2-/- recipients. In contrast to SJL bone marrow recipients that were grossly normal, 
both CD4-Cre x ICN1 and SJL/NIC mix recipients developed disease. CD4-Cre x ICN1 
bone marrow chimeras exhibited weight loss, thymic involution, and neutrophilia, with 
SJL/NIC mixed chimeras showing comparable thymic atrophy and elevated granulocyte 
numbers and a trend toward a decrease in weight (Figure 3-5A-D). 
 
As both CD4-Cre x ICN1 and SJL/ CD4-Cre x ICN1 bone marrow chimeras developed 
disease similar to that observed in CD4-Cre x ICN1 mice, we next tested whether ICN1 
expression in CD4+ T cells from these bone marrow chimeras also promoted the 
differentiation of multiple Th cell subsets. Splenocytes from SJL, CD4-Cre x ICN1, and 
SJL/ CD4-Cre x ICN1 mixed bone marrow chimeras were stimulated ex vivo with PMA 
and ionomycin and cytokine production was assessed by intracellular flow cytometry. 
Restimulated SJL CD4+ T cells demonstrated the capacity to produce both IFNγ and IL-
2, but minimal capacity to produce IL-4 or IL-17A (Figure 3-5E). SJL, GFP-CD4+ T cells 
from SJL/ CD4-Cre x ICN1 mixed chimeras also displayed IFNγ and IL-2 production and 
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a limited capacity to produce IL-17A, but showed an increased capacity to produce IL-4, 
compared to SJL single chimeric CD4+ T cells, suggesting that the presence of CD4-Cre 
x ICN1 T cells in the mixed chimera culture affected cytokine production by SJL cells in 
trans (Figure 3-5E). Unlike SJL cells from either culture, GFP+CD4+ T cells from both 
CD4-Cre x ICN1 single chimeras or SJL/ CD4-Cre x ICN1 mixed chimeras displayed an 
increased capacity to produce all four cytokines, including the emergence of IL-4+IFNγ+ 
and IL-17A+IL-2+ multi-cytokine producing populations, consistent with a role for Notch in 
concurrently promoting multiple Th cell programs (Figure 3-5E). Altogether, these data 
indicate that the disease observed in CD4-Cre x ICN1 mice is T cell autonomous and 
that the CD4-Cre x ICN1 CD4+ T cell poly-differentiated phenotype cannot be promoted 
in trans. 
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Figure 3-5: T cell defects in CD4-Cre x ICNFL/FL are cell autonomous. Bone marrow 
cells from SJL, CD4-Cre x ICNFL/FL, or both SJL and CD4-Cre x ICNFL/FL mice were 
adoptively transferred into lethally irradiated SJL recipients. After 6 weeks, mice were 
analyzed. (A) Body weight of recipient mice. (B) Total thymocytes number in recipient 
mice. (C) Absolute number of neutrophils in spleens of recipient mice. (D) Neutrophil 
frequency in spleens of chimeric mice. (E) Lymph node cells from recipient mice were 
stimulated ex vivo with PMA and ionomycin and analyzed by intracellular flow cytometry 
for the production of IL-4, IFNγ, IL-17A, and IL-2. 
 
A. 
D. 
B. C. 
E. 
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Notch signaling destabilizes the initiation, but not the maintenance, of Treg differentiation 
In addition to causing autoinflammation by promoting the differentiation of multiple 
inflammatory Th cell subsets, it remained possible that Notch signaling further 
exacerbated this phenotype by destabilizing Treg cell differentiation. To address this, we 
assessed the Treg content of CD4-Cre x YFPFL/FL and CD4-Cre x ICN1 mice by flow 
cytometry. In both the thymus and spleen of CD4-Cre x ICN1 mice, the Foxp3+ Treg cell 
population was decreased, suggesting that CD4-Cre x ICN1 Treg differentiation might be 
less efficient (Figures 5A-B). To test whether CD4-Cre x ICN1 T cells were refractory to 
Treg differentiation, CD4+ T cells from either CD4-Cre x YFPFL/FL or CD4-Cre x ICN1 
mice were activated in vitro under Treg polarizing conditions and Foxp3 expression was 
assessed after five days. While CD4-Cre x YFPFL/FL T cells were capable of inducing 
Foxp3 expression, CD4-Cre x ICN1 T cells were refractory to Treg differentiation, 
consistent with in vivo findings (Figure 3-6C). 
 
We next sought to establish whether the decreased Treg capacity in CD4-Cre x ICN1 
CD4+ T cells was cell autonomous, or secondary to the Notch pathway’s ability to 
promote multiple inflammatory Th cell subsets. Splenocytes from SJL, CD4-Cre x ICN1, 
or SJL/ CD4-Cre x ICN1 mixed bone marrow chimeric mice were analyzed by flow 
cytometry for Foxp3 expression.  Whereas SJL bone marrow recipients exhibited an 
appreciable Treg population, Foxp3+ cells were nearly absent in CD4-Cre x ICN1 
chimeras (Figure 3-6D-E). Similarly, the GFP+ CD4-Cre x ICN1 compartment in SJL/ 
CD4-Cre x ICN1 mixed bone marrow chimeras displayed a paucity of Tregs and reduced 
frequency compared to CD45.1+ SJL cells in the same mice, indicating that this 
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phenotype was likely cell autonomous. These mice also demonstrated a trend toward 
decreased Tregs within the CD45.1+ SJL compartment, albeit still greater than observed 
amongst GFP+ cells, indicating that the Treg deficiency phenotype may be in part due to 
trans effects from the enhanced cytokine production by CD4-Cre x ICN1 T cells (Figure 
3-6D-E). 
 
To exclude the possibility that the decreased Treg cell population in the CD4-Cre x ICN1 
mice resulted from being exposed to an environment of excess cytokine production, we 
utilized a Tat-Cre model. This system allows for transient and acute Cre-mediated 
deletion, thus permitting us to study ICNFL/FL T cells that develop in an otherwise WT 
environment in vivo and then can be induced to express ICN1 in vitro. CD4+ T cells from 
either YFPFL/FL or ICN1FL/FL were treated with Tat-Cre and rested overnight, after which 
naïve YFP+/GFP+ T cells were sorted and activated under Treg polarizing conditions. As 
expected, YFPFL/FL cells were capable of initiating Foxp3 expression under these 
conditions. In contrast, ICN1FL/FL T cells displayed a decreased Treg differentiation 
capacity, indicating that the inflammation present in CD4-Cre x ICN1mice is not the 
primary cause for the loss in Treg differentiating capacity (Figure 3-6E). 
 
Having confirmed that enforced Notch1 signaling is sufficient to impair Treg 
differentiation in a cell autonomous manner, we asked whether Notch1 signaling 
inhibited the initiation of the Treg program or acted to destabilize the maintenance of the 
Treg identity. To address this, Foxp3-Cre mice were bred to either YFPFL/FL or ICN1FL/FL 
mice, such that constitutive Notch signaling is induced after the Treg program has been 
initiated. Naïve CD4+ T cells from either Foxp3-Cre x YFPFL/FL or Foxp3-Cre x ICN1FL/FL 
mice were activated under Treg polarizing conditions and Foxp3 expression was 
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assessed by intracellular flow cytometry. Unlike the CD4-Cre or Tat-Cre models, in 
which ICN1 expressing cells were refractory to Treg differentiation, Foxp3-Cre x YFPFL/FL 
and Foxp3-Cre x NICFL/FL exhibited a comparable capacity for Treg differentiation in this 
model, indicating that once Foxp3 expression is initiated, Notch signaling is no longer 
sufficient to destabilize the Treg program (Figure 3-6F). Thus, Notch signaling acts to 
impair the initiation of Treg differentiation. 
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Figure 3-6: Impaired Treg induction in CD4-Cre x ICNFL/FL mice. (A) Frequency of 
CD4+Foxp3+ cells in the (A) thymus and (B) spleen of CD4-Cre x YFPFL/FL, CD4-Cre x 
DNMAMLFL/FL, and CD4-Cre x ICNFL/FL mice.  (C) CD4+ T cells from CD4-Cre or CD4-
Cre x ICNFL/FL mice were stimulated as above under Treg polarizing conditions. After 5 
days, cells were analyzed by flow cytometry for Foxp3 expression. Bone marrow cells 
from SJL, CD4-Cre x ICNFL/FL, or both SJL and CD4-Cre x ICNFL/FL mice were adoptively 
transferred into lethally irradiated SJL recipients. (D) Absolute numbers of splenic Tregs 
and (E) frequency was assessed by flow cytometry. (F) CD4+ cells from YFPFL/FL and 
ICNFL/FL mice were treated with Tat-Cre, rested for 24 hours, and then YFP+ or GFP+ 
CD4+ T cells were sorted. T cells were then stimulated as above under Treg polarizing 
conditions. After 5 days, cells were analyzed by intracellular flow cytometry for Foxp3 
expression. (G) CD4+ T cells from Foxp3-Cre x YFPFL/FL and Foxp3-Cre x ICNFL/FL mice 
were stimulated as above under Treg polarizing conditions. After 5 days, Foxp3 
expression was analyzed by flow cytometry. 
A. D. 
B. 
C. 
E. 
F. 
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Notch signaling desensitizes activated CD4+ T cells to TGF-β and is a key regulator of 
the Th9-Treg and Th17-Treg axes 
 
We previously demonstrated that Notch signaling acts to potentiate multiple 
inflammatory Th cell programs by sensitizing activated CD4+ T cells to inflammatory 
differentiating cues. Because enforced Notch1 signaling destabilized Treg differentiation, 
we hypothesized that the Notch pathway might similarly desensitize activated CD4+ T 
cells to TGF-β, the primary Treg differentiating factor. To test this hypothesis, we 
activated WT naïve CD4+ T cells in the presence or absence of the pharmacological 
Notch inhibitor GSI (γ-secretase inhibitor), under a series of serially diluted TGF-β 
concentrations, with IL-2 being held constant. Predictably, as TGF-β was titrated down, 
decreased Treg differentiation was observed in vehicle control treated (DMSO) cultures 
(Figure 3-7A). In contrast, Notch-inhibited cultures were resistant to decreased TGF-β 
concentrations and maintained robust Treg differentiating capacity even in 64-fold 
diluted TGF-β, where minimal Foxp3 expression is observed in control cultures (Figure 
3-7A). As both IL-4 and IFNγ can destabilize Treg differentiation and inhibition of Notch 
signaling results in decreased production of both these ctyokines, the ability of GSI 
treatment to stabilize Treg differentiation in limiting TGF-β may merely result from 
decreased IL-4 and IFNγ in these culture. To exclude this possibility, we repeated the 
TGF-β titration cultures in the presence of neutralizing anti-IL-4 and anti-IFNγ antibodies. 
While DMSO treated cultures displayed decreased Treg differentiation as TGF-β 
concentrations became limiting, GSI treated cultures displayed high levels of Treg 
differentiation at concentrations that failed to support this population in control conditions 
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(Figure 3-7B). It is worth noting that the effect of GSI at lower TGF-β concentrations was 
not as robust when neutralizing antibody was present, suggesting that while the 
dominant effect of Notch inhibition is TGF-β-desensitization, loss of inflammatory 
cytokine production likely also contributes. 
 
To verify that the enhanced TGF-β sensitivity observed in GSI treated cultures was due 
to effects on the Notch pathway and not another γ-secretase-dependent process, we 
repeated the TGF-β titration assay using either Tat-Cre treated YFPFL/FL or DNMAMLFL/FL 
CD4+ T cells. Similar to GSI treatment, DNMAML expressing T cells retained an 
elevated Treg differentiating capacity at limiting doses of TGF-β, whereas YFPFL/FL cells 
lost Foxp3 expression as TGF-β was diluted in the culture (Figure 3-7C).  These data 
indicate that while Notch signaling sensitizes activated T cells to inflammatory 
differentiating cues, it concurrently acts to desensitize these cells to TGF-β-derived 
signals, thus providing a mechanistic basis for the Treg phenotype observed in ICN1 
mice. 
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Figure 3-7: Notch signaling desensitizes activated T cells to TGFβ . WT CD4+ T cells 
were stimulated as described and then cultured in the presence of either DMSO or GSI 
with media containing (A) a titration series of four-fold serially diluted TGFβ and constant 
IL-2 or (B) or the same titration series plus anti-IL-4 and anti-IFNγ. After 5 days, cells 
were analyzed for Foxp3 expression by intracellular flow cytometry. (B) CD4+ cells from 
YFPFL/FL and DNMAMLFL/FL mice were treated with Tat-Cre, rested for 24 hours, and then 
YFP+ or GFP+ CD4+ T cells were sorted. T cells were then stimulated and then cultured 
in a titration series of four-fold serially diluted TGFβ and constant IL-2. After 5 days, cells 
were analyzed by intracellular flow cytometry for Foxp3 expression.  
A. B. 
C. 
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Given the Notch pathway’s unique role in regulating T cell sensitivity to both 
inflammatory and regulatory cues, we predicted that this would place Notch as a key 
regulator of the Th17-Treg and Th9-Treg axes. The inflammatory Th subsets, Th17 and 
Th9, each require the presence of both TGF-β and the inflammatory cytokines IL-6 and 
IL-4, respectively, to initiate their differentiation programs. Thus, as inflammatory 
cytokines become limiting, Notch signaling should regulate a switch in the choice 
between an inflammatory or regulatory Th cell fate under these complex cytokine 
conditions. We previously showed that when IL-6 is serially diluted from Th17 conditions 
in the presence of GSI that IL-17A production is rapidly lost, compared to vehicle control, 
however it remained unclear if Notch inhibition can still promote Treg differentiation in 
conditions that favor inflammatory Th cell differentiation.  
 
To test our hypothesis, naïve CD4+ T cells from WT mice were activated under either 
Th17 or Th9 conditions, with IL-6 and IL-4, respectively, being serially diluted and TGF-β 
held constant. As expected, titrating IL-6 from the culture in the presence of DMSO 
resulted in increased Foxp3 expression (Figure 3-8A). When these cells were cultured in 
the presence of GSI, Foxp3 expression was more readily induced and expressed in a 
greater fraction of cells at all IL-6 concentrations, suggesting that Notch inhibits Treg 
differentiation and stabilizes Th17 differentiation in order to lower the cytokine threshold 
for commitment (Figure 3-8A).  
 
Similar to titrating IL-6, serial dilution of IL-4 resulted in a gradual decrease in Gata3 
expression and eventually complete destabilization of Th9 differentiation at 256-fold 
diluted IL-4 (Figure 3-8B). Unlike Th17 differentiation, which was more readily 
destabilized at lower concentrations of IL-6, Th9 differentiation remained remarkably 
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stable when Notch signaling was permitted, with Gata3 being expressed in nearly all 
cells until IL-4 was markedly diluted. In contrast, when Notch signaling was inhibited, 
Th9 differentiation was markedly destabilized. Gata3 expression was lost at 4-fold 
diluted IL-4 in the absence of Notch signaling and the majority of cells were Gata3- at 
lower concentrations (Figure 3-8B). Conversely, Foxp3 expression was more readily 
induced at higher concentrations of IL-4 and accumulated as a Foxp3+Gata3- population 
at the lowest concentrations, whereas the majority of Foxp3+ cells in control cultures 
retained Gata3 expression (Figure 3-8B). Altogether these data indicate that Notch 
signaling plays a critical role in stabilizing inflammatory Th cell differentiation by 
antagonizing Treg differentiation in the presence of a complex cytokine milieu. 
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Figure 3-8: Notch is a critical regulator of the Th17-Treg and Th9-Treg axes. 
WT CD4+ T cells were stimulated as described and then cultured in a titration 
series of four-fold serially diluted (A) IL-6 or (B) IL-4 and constant TGFβ in the 
presence of either DMSO or GSI. After 5 days, cells were analyzed by intracellular 
flow cytometry. 
A
. 
B. 
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Discussion 
The Notch pathway frequently functions as a potent instructional pathway, classically 
involved in bipotential fate decisions during development(Radtke et al., 2010). We 
recently reported a role for Notch as an unbiased amplifier of multiple inflammatory Th 
cell subsets, which is mechanistically distinct from its instructional role during T lineage 
development before β-selection. Here we tested the hypothesis that Notch signaling 
plays unique roles pre- and post-β-selection by expressing a constitutively active form of 
Notch1 under the control of CD4-Cre. Unlike studies in which activation of Notch 
signaling prior to β-selection resulted in T lineage instruction and drove T-ALL onset, 
CD4-Cre ICN1 mice fail to develop leukemia and instead exhibit a lethal 
autoinflammatory disorder mediated by a cell autonomous increase in Th1, Th2, and 
Th17 differentiation. Additionally, our studies revealed a novel role for Notch signaling in 
inhibiting Treg differentiation, by desensitizing activated CD4+ T cells to TGFβ. 
 
The role of the Notch pathway as an instructor of normal and malignant T lineage 
development is well known. Constitutive activation of Notch signaling is sufficient to 
launch the T lineage program and induce leukemia in multiple models. Early studies 
showed that retroviral expression of ICN1 in bone marrow progenitors resulted in de 
novo T cell development outside of the thymus, at the expense of B cell development, 
and ultimately T-ALL onset(Allman et al., 2001; Pear et al., 1996; Pui et al., 1999). 
Conversely, without the instructive signals derived from Notch, T lineage development 
fails to occur and B cell development can be observed in the thymus(Han et al., 2002; 
Maillard et al., 2004; Radtke et al., 1999). Even after progenitors commit to the T 
98 
 
lineage, enforced Notch signaling has the capacity to instruct a T-ALL program. 
Expression of ICN1 using Lck-Cre, which is active prior to β-selection, results in 
thymocyte expansion and drives T-ALL, while Lck-Cre x ICN3FL/FL mice similarly exhibit 
increased thymocyte cellularity and T-ALL(Bellavia et al., 2000; Bellavia et al., 2002; 
Deftos et al., 2000; Robey et al., 1996). 
 
Our work using CD4-Cre x ICN1FL/FL mice now illustrates that these potent pro-leukemic 
and instructional activities exerted by the Notch pathway at early stages of T lineage 
development are lost after β-selection. Cre expression in this model begins after TCRβ is 
expressed and peaks between the DP and SP stages of thymocyte development(Shi 
and Petrie, 2012; Wolfer et al., 2002). Although all NIC mice analyzed in our study died 
by 6 months after birth, this was due to a severe autoinflammatory disorder and none of 
the mice developed leukemia. This finding is consistent with the observation that 
inactivation of the Notch pathway in the T cell compartment after β-selection results in no 
gross developmental defects and only yields phenotypes after peripheral T cells are 
activated(Amsen et al., 2004; Maillard et al., 2004; Tu et al., 2005; Wolfer et al., 2002). 
 
Similar gain-of-function studies have also been used to contend that Notch instructs 
fates at later stages of T cell development. Retroviral expression of ICN1 in activated T 
cells was suggested to selectively instruct the differentiation of individual Th cell subsets. 
Enforced Notch activation in Th cells has been shown to solely instruct Th2 
differentiation in multiple studies, while other groups have reported the selective 
induction of IFNγ and Tbet by intracellular forms of Notch(Amsen et al., 2007; Amsen et 
al., 2004; Fang et al., 2007; Maekawa et al., 2003; Minter et al., 2005). While our in vivo 
99 
 
model of Notch activation agrees insofar that Notch signaling can support both Th1 and 
Th2 differentiation, we fail to see any selectivity or instruction by Notch signaling with 
regard to cytokine production by Th cells. Instead, we observe a concurrent and cell-
autonomous increase in Th1, Th2, and Th17 differentiation, consistent with our 
molecular and loss-of-function findings that the Notch pathway simultaneously amplifies 
the differentiation of multiple inflammatory Th cell subsets(Bailis et al., 2013). It is likely 
that the discrepancies between our in vivo study and previous in vitro studies using ICN 
stems from the fact that Notch signaling acts to sensitize activated T cells to exogenous, 
inflammatory differentiating cues(Bailis et al., 2013). Thus, the manner in which an in 
vitro differentiation system is established can yield seemingly instructive phenotypes for 
ICN expression if these conditions have an inherent bias toward Th1 or Th2 
differentiation. Indeed, in the same study that ICN1 was shown to instruct Th2 
differentiation in vitro, loss of Gata3 in this model resulted in Th1 “instruction” by 
ICN1(Amsen et al., 2007). Finally, these new gain-of-function findings exclude the 
possibility that our loss-of-function studies masked a dose-dependent instructional role 
for Notch signaling in Th cell differentiation and show that the Notch pathway is both 
necessary and sufficient in potentiating multiple fate outcomes in the peripheral T cell 
compartment, under weak differentiating conditions. 
 
In addition to simultaneously promoting differentiation of multiple inflammatory Th cell 
subsets, our study also evinces a new role for the Notch pathway in destabilizing Treg 
differentiation. In keeping with a model in which Notch signaling functions as an 
integrator of exogenous cues, we find that Notch acts to desensitize activated T cells to 
environmental TGFβ during the initiating of Treg differentiation, but fail to see this effect 
after Foxp3 is already expressed. Moreover, our mixed bone marrow chimera 
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experiments indicate this is a cell-autonomous function. Nonetheless, previous studies 
have argued for a positive regulatory role for Notch in Treg differentiation. In one study, 
inhibition of Notch signaling using either GSI or an antisense transgene was suggested 
to impair Treg differentiation(Samon et al., 2008). The differences between our findings 
may be accounted for by the high levels of ICN observed in the other study’s GSI-treated 
and Notch1-antisense samples. Additionally, our studies used naïve CD4+ T cells and 
antigen presenting cells for our in vitro assays, in contrast to the use of total CD4+CD25- 
cells and plate-bound antibody. In another study, Lck-Cre x ICN3FL/FL mice displayed a 
substantial expansion of CD25+Foxp3- cells, but also exhibited a roughly three-fold 
expansion of CD25+Foxp3+ cells with enhanced suppressor function. This expanded 
Treg population is lost when ICN3-transgenic mice are crossed to Ptcra-/- mice, 
indicating that these cells are likely naturally occurring Tregs and may suggest distinct 
roles for Notch in thymic and peripheral Treg populations (Anastasi et al., 2003; 
Campese et al., 2009). It is also worth noting that autoinflammatory disorders have not 
been observed in T cell-specific conditional loss-of-function Notch models, as would be 
predicted if Treg differentiation were impaired, and instead defects in inducing 
inflammation are present(Radtke et al., 2013). Our studies are consistent with a role for 
Notch as a negative regulator of Treg differentiation  as autoinflammation results from 
Notch1 gain-of-function.  
 
In summary, our gain- and loss-of-function data evince a role for Notch as an unbiased 
integrator of exogenous differentiation cues that act to sensitize T cells to inflammatory 
signals and desensitize T cells to regulatory signals. This model is consistent with our 
observation that the Notch pathway is a key regulator of the balance of regulatory and 
inflammatory Th cell populations that are activated under complex cytokine mixtures, 
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such as Th9 and Th17 differentiation. While a role for Notch in Th9 and Th17 
differentiation has been previously reported (REFS), we find that loss of Notch signaling 
not only destabilizes the differentiation of these subsets, but also enhances Treg 
differentiation under conditions that otherwise would not favor this population(Elyaman et 
al., 2012; Keerthivasan et al., 2011; Mukherjee et al., 2009). Indeed, Notch inhibition 
concurrently results in impaired Th17 differentiation and enhanced Treg differentiation in 
experimental autoimmune encephalomyelitis(Bassil et al., 2011; Keerthivasan et al., 
2011; Sandy et al., 2013). Moreover, inhibiting the Notch pathway has also been found 
to simultaneously impair Th1, Th2, and Th17 differentiation while enhancing Treg 
differentiation in a mouse model of graft-versus-host disease(Tran et al., 2013; Zhang et 
al., 2011). Our findings now provide a mechanistic basis for these observations and 
further highlight the utility of Notch inhibition as a therapeutic for inflammatory disorders. 
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CHAPTER 4: Discussion and Future Directions 
Lineage development is directed both by extrinsic environmental cues, in the form of 
soluble mediators and cell-surface molecules, and intrinsic regulation of transcription at 
the level of transcription factors, chromatin conformation, and epigenetic modification.  
The context and manner in which a developing cell integrates this wide range of inputs 
ultimately dictates the fate choices that the cell will make. Within the hematopoietic 
system, T lineage development is one of the best characterized developmental 
pathways, with both extrinsic and intrinsic mediators known for multiple well defined 
developmental stages (Rothenberg et al., 2010). Yet despite our wealth of knowledge on 
the development of this essential immune population, we have little understanding of 
how many of the intrinsic mediators of T lineage development exert distinct functions at 
multiple stages in the T lineage progression. For example, Gata3 is understood to be 
essential for early T lineage commitment of all αβ-T cells, the induction of CD4+ SP (but 
not CD8+ SP) thymocyte development, and finally the selective instruction of Th2 
differentiation at the expense of other Th cell fates (Rothenberg and Scripture-Adams, 
2008). Moreover, Gata3 has been found to regulate distinct sets of transcriptional targets 
at each of these stages, an observation that cannot solely be explained by transcription 
factor concentration and/or motif binding affinity (Wei et al., 2011). Here I present 
findings that illustrate how the Notch pathway similarly exerts unique functions at early 
and late T cell development. While Notch signaling displays strong instructional capacity 
prior to the β-selection checkpoint, I find that Notch signaling lacks this ability thereafter 
and instead acts to potentiate multiple Th cell fates by sensitizing activated CD4+ T cells 
to exogenous differentiating cues, thus functioning as a signal integrator. The 
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implications for these findings on Notch signaling in T lineage development, T-ALL 
transformation, and development of non-T populations within the hematopoietic system 
are discussed in this chapter. 
 
Two paradigms of Notch signaling, one lineage 
The Notch pathway is a potent lineage instructor during early hematopoietic 
development. Enforced Notch signaling in bone marrow progenitors is sufficient divert 
cells with lymphoid potential away from the B lineage and launch the T lineage program, 
while loss of Notch signaling renders the thymus barren of its ability to foster T lineage 
development (Allman et al., 2001; Pear et al., 1996; Pui et al., 1999; Radtke et al., 
1999). Even in the absence of an ICN transgene, Notch ligand stimulation is sufficient to 
divert myeloid progenitor cells into the T lineage (Chi et al., 2011). This instructive 
capacity of Notch is so pronounced that T lineage cells develop outside of the thymus 
when signaling is constitutively on, illustrating that Notch signaling itself, not other 
components of the thymic microenvironment, dictates entry into T development. 
 
Mechanistically, Notch signaling is understood to instruct T cell development by 
coordinating the expression of genes that directly program the T lineage identity as well 
as genes that function to restrict alternate fates. The TCR is fundamental to the T cell 
identity and core function and the Notch pathway is understood to regulate several key 
stages of its assembly. As discussed in Chapter 1, Notch signaling is essential for the 
first stages of TCR assembly. Notch both directly and indirectly regulates Ptcra, by 
binding to the Ptcra promoter to drive transcription and by promoting the splicing of 
Ikaros isoforms that lack DNA binding capacity (Bellavia et al., 2007; Reizis and Leder, 
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2002). Moreover, RBPJ-deficient thymocytes display impaired TCRβ rearrangement, 
suggesting that Notch regulates pre-TCR signaling at the level of both pTa and TCRβ 
(Ciofani et al., 2006; Wolfer et al., 2002). In addition to regulating TCR assembly, Notch 
signaling controls the expression of three of the most important T lineage commitment 
factors: Gata3, Tcf7 (Tcf1), and Bcl11b (Rothenberg, 2012; Rothenberg et al., 2010). 
All three of these factors are required for early T development and, in addition to 
regulating a network of key T lineage identity genes, Tcf1 and Bcl11b act to restrict 
alternate lineage programs. While Bcl11b limits NK and myeloid potential and terminates 
gene expression associated with the stem/progenitor program, Tcf1 plays an important 
role in restraining B cell development (Ikawa et al., 2010; Li et al., 2010a; Li et al., 
2010b; Weber et al., 2011). Furthermore, the canonical Notch target Hes1 has recently 
been shown to constrain myeloid development within the thymus (De Obaldia et al., 
2013). Finally, Notch further promotes T lineage development by providing a growth and 
survival advantage for T committed cells, via the direct regulation of two essential 
thymocyte survival factors: Il7ra and Myc (Gonzalez-Garcia et al., 2009; Wang et al., 
2014; Weng et al., 2006). Thus, the Notch pathway instructs T lineage development by 
promoting the assembly of the TCR, launching the core T lineage transcriptional 
network, restricting alternate fates, and promoting the outgrowth of committed cells. 
 
In contrast to the multilayered instructional capacity of Notch during early T 
development, the work presented in Chapters 2 illustrates the lack of instruction by the 
same pathway during late-stage T development. Like its regulation of T lineage defining 
factors such as the TCR and the core T lineage transcriptional network, Notch signaling 
similarly regulates the signature effector proteins and transcription factors of Th cells. 
105 
 
However, instead of supporting a single Th cell subset, Notch simultaneously binds and 
directly regulates Il4, Ifng, Il17a, Gata3-1a, Tbx21, and Rorc, early after T cell activation. 
This activity appears to only be essential when environmental differentiation cues are 
limiting, as Th cells can differentiate successfully in the absence of Notch at high 
cytokine concentrations, whereas the requirement for Notch signaling in T lineage entry 
is absolute.  The gain-of-function studies presented in Chapter 3 further illustrate the 
Notch pathway’s ability to promote the differentiation of multiple Th cell populations in 
vivo, in contrast to the selective induction of T cell development when Notch signaling is 
enforced prior to β-selection (Allman et al., 2001; Pear et al., 1996; Pui et al., 1999). 
Insofar as the Notch pathway restricts alternate fates during Th cell differentiation, Treg 
induction is destabilized in the face of constitutive Notch signaling, however residual 
Treg differentiation capacity persists. This is in contrast to the complete loss of B cell 
potential in ICN1 transduced bone marrow cells, suggesting that, while the Notch 
pathway does retain properties of lineage restriction in peripheral T cells, this activity is 
modest compared to its function in thymocyte development (Pui et al., 1999).  
 
Finally, the extent to which Notch signaling provides a survival or proliferative advantage 
to signal receiving cells during Th cell differentiation remains less clear. Dll4 stimulation 
can enhance T cell survival following activation and mice deficient in components of the 
Notch pathway display decreased proliferation and survival following immunization with 
adjuvant and peptide (Helbig et al., 2012). Additionally, another report described an 
important role for Notch signaling in promoting T cell proliferation via Myc, downstream 
of the TCR (Guy et al., 2013). While these two studies suggest that Notch can play a 
role in peripheral T cell growth and survival, other loss-of-function Notch studies in 
peripheral T cells have reported no effect of Notch on T cell proliferation following 
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activation, suggesting that Notch effects on these processes are likely to be context 
dependent, much like the relationship between Notch and cytokines (Amsen et al., 2004; 
Bailis et al., 2013; Minter et al., 2005; Tu et al., 2005). Nonetheless, both these studies 
failed to report any selective preference of Notch signaling in promoting the survival of 
individual Th cell subsets, suggesting that while the pathway may similarly regulate 
growth and survival during early and late T lineage development, this activity does not 
impart any instructive capacity to Notch during Th cell differentiation as it does during T 
lineage entry. 
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Figure 4-1: Two paradigms of Notch signaling. (A) Notch can function as a 
lineage instructor during development, as seen in early thymocyte development. 
The Notch transactivation complex is capable of binding and directly activating 
genes that define lineage identity (i.e. Tcrb), genes that govern lineage commitment 
(i.e. Bcl11b), and genes the control cells survival and proliferation (i.e. Myc). In turn, 
lineage commitment factors suppress alternate fate potentials and survival factor 
promote the outgrowth of committed cells, enforcing lineage identity. (B) Notch also 
has the capacity to function as an integrator of exogenous differentiating cues, as 
seen in Th cell differentiation. In the absence of other activating signals, the Notch 
transactivation complex binds to lineage commitment and identity genes for multiple 
lineage programs (i.e. Gata3, Tbx21, and Rorc) in an impartial manner, sensitizing 
them to transactivation by other pathways. Upon receiving lineage-biasing signals, 
transcriptional activators are recruited to genes that promote the differentiation of a 
single lineage (i.e. Tbx21 only) by synergizing with Notch complexes at those sites. 
Subsequently, the activated lineage commitment factors repress transcription at loci 
for alternate lineages, reinforcing differentiation. During this process, Notch also 
provides cell survival and growth signals to all differentiated cells, regardless of 
lineage. In this setting, Notch remains capable of synergizing with new activating 
signals that may re-differentiate this cell to an alternate fate. 
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Rather than supporting an instructional model, the data presented here suggest the 
Notch pathway acts to integrate a wide array of environmental cues into a coherent 
transcriptional program. I have shown this at the level of cytokine sensitization and the 
ability of Notch to synergize with components of these pathways at Th cell signature 
gene loci, however data from other groups indicate that Notch can similarly integrate 
signals from other pathways. As mentioned above, Notch signaling can act directly 
downstream of the TCR. Signal transduction downstream of the TCR is mediated via the 
phosphorylation of multiple conserved motifs (ITAMs) found on CD3 proteins (Love and 
Hayes, 2010). Upon T cell activation, Guy and colleagues detected the recruitment of 
Notch1 and components of the Notch cleavage machinery to the TCR, in a manner 
dependent on high ITAM multiplicity. Given Notch signaling was also found to induce 
Myc transcription and Myc expression was found to be reduced in cells with low ITAM 
multiplicity or activated with weak TCR agonists, it was postulated that Notch signaling 
directly couples proliferation and cell growth to TCR signal strength, and thus functions 
as a rheostat for activation as dictated by antigen affinity (Guy et al., 2013). In addition to 
acting directly downstream of the TCR, Notch signaling has also been suggested to 
interact with other critical T cell activation pathways. Notch inhibition after T cell 
activation impairs sustained activation of NF-κB and ICN1 may even directly interact with 
components of NF-κB signaling. Moreover, Notch was found to cooperate with NF-κB 
and regulate transcription at the Ifng promoter, illustrating its ability to integrate signals 
from other pathways to mediate transcription of key T cell effector genes, much like we 
observed for Notch and Tbet (Shin et al., 2006). Similarly, Smad3 directly interacts with 
Notch1 and the two factors have been shown to cooperatively promote Il9 transcription 
(Elyaman et al., 2012). Notch inhibition is also associated with a hyporesponsive 
phenotype in CD4+ and CD8+ T cells from a mouse model of GvHD. These cells display 
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decreased NF-κB and Ras/MAPK signaling and increased expression of negative 
regulators of T cell activation, such as Dgka, Cblb, and Pdcd1, suggesting that Notch 
signaling may act as a global integrator of activating signals (Sandy et al., 2013). While 
Notch signaling has been found to interact with these pathways and others (such as 
PI3K, Hedgehog, Wnt, and mTOR) in cancer and other cell types, the extent to which 
Notch collaborates with the downstream transcriptional effectors from these networks in 
activated T cells has not been evaluated and is an area of investigation for future studies 
(Aster et al., 2011; Takebe et al., 2011). 
 
Although this thesis reports findings indicative of a non-instructional role for Notch during 
Th cell differentiation, this observation has only been made at the population level. Our 
ChIP and GSI-washout data demonstrate that Notch can bind and directly regulate the 
signature cytokine and transcription factor genes for Th1, Th2, and Th17 cells, but they 
do not prove that this occurs simultaneously in the same cell. It remains possible that at 
the single cell level, the Notch complex may display Th cell type specific activity, such 
that Notch only binds to Ifng and Tbx21 in cells initiating Th1 differentiation, but not in 
cells that have begun Th2 or Th17 differentiation. While this would still entail the Notch 
pathway’s involvement in the differentiation of multiple populations from the same 
progenitor, in contrast to thymocytes, it would be more consistent with what has been 
observed for Notch in earlier stages of development: Notch selectively regulates cell-
type defining genes in individual cells, these targets (e.g. Tbet) coordinate core 
transcriptional networks and restrict alternate fates, and Notch then selects for 
differentiated cells by promoting growth and survival. Single-cell array or RNA-seq 
studies performed on GSI-washout samples will go a long way to addressing this, 
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however until ChIP technology becomes reliable in resolving transcription factor binding 
at the single-cell level, these questions will likely remain difficult to directly address. 
 
Implications for Notch signaling and T-ALL 
The gain-of-function studies performed in Chapter 3 not only highlight a switch in Notch 
instructional activity during normal development, before and after β-selection, but also 
demonstrate a striking and concurrent switch in Notch oncogenic activity in promoting 
malignant development. Multiple studies have shown that activation of Notch signaling 
before β-selection, either using retroviral transduction or Lck-cre, results in highly 
penetrant, rapid onset, and lethal T-ALL (Allman et al., 2001; Bellavia et al., 2000; 
Bellavia et al., 2002; Deftos et al., 2000; Pear et al., 1996; Pui et al., 1999; Robey et al., 
1996). The data in Chapter 3 show that activation of Notch after β-selection, using CD4-
cre, fails to result in T-ALL and instead promotes the differentiation of multiple 
inflammatory Th cell subsets, while destabilizing Treg development (Figure 4-2). These 
findings raise fundamental questions about the mechanisms Notch signaling utilizes to 
induce T-ALL. 
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Figure 4-2: Notch signaling mediates distinct functions pre- and post-β-
selection. Prior to β-selection, Notch signaling is a robust instructor of cell fate. 
Activated Notch signaling instructs T lineage development at the expense of B cell 
development, and hyper-activation of the pathway diverts progenitors into a 
malignant developmental pathway. After β-selection is completed, Notch signaling is 
turned off for the duration of thymic development. If Notch signaling is enforced 
during this period, it is incapable of launching a T-ALL program. Instead, maturing T 
cells readily activate and differentiate into multiple inflammatory Th cell subsets that 
in turn promote autoinflammation. Similarly, when Notch signaling is naturally 
initiated after a naïve CD4+ T cell becomes activated, the pathway acts to integrate 
environmental differentiation cues in a manner that sensitizes activated cells to 
inflammatory Th cell differentiation and destabilizes Treg differentiation. 
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Notch is thought to promote T-ALL onset through its ability to regulate multiple pro-
survival and pro-proliferative pathways. Among these genes, c-Myc has been identified 
as the critical Notch target in T-ALL, both necessary and sufficient for Notch driven 
leukemia (Palomero et al., 2006; Sharma et al., 2006; Weng et al., 2006). Additionally, 
Notch signaling has been shown to regulate the NF-κB and AKT pathways to promote 
malignancy, though neither is sufficient for T-ALL (Landor et al., 2011; Lee et al., 2012; 
Palomero et al., 2007; Vilimas et al., 2007). One possible explanation for the inability of 
hyper-active Notch signaling to induce leukemia after β-selection is that one or more of 
these critical T-ALL targets are inaccessible to Notch at later stages of development. In 
particular, we have identified a long-distance, Notch dependent Myc enhancer that is 
active in both in DN3 thymocytes and T-ALL and required for Notch activation of Myc (in 
submission). It will be interesting to test whether Notch can still occupy this element, 
whether the enhancer continues to loop to the Myc promoter, and/or whether this 
enhancer remains active after β-selection. In addition to local studies at the Myc 
enhancer, ChIP-seq analyses for Notch1 and RBPJ comparing ICN1 transduced bone 
marrow progenitors and DN3 cells from Lck-cre x ICN1FL/FL mice to DP and peripheral 
CD4+ and CD8+ cells from CD4-cre x ICN1FL/FL mice will go a long way to clarifying Notch 
target accessibility before and after β-selection. Combining this approach with RNA-seq 
and ChIP-seq for various histone modifications in the above populations versus control 
cells (i.e. Lck-cre x ICN1FL/FL DN3 cells versus Lck-cre x YFPFL/FL DN3 cells) will help 
resolve the network of genes that the Notch pathway is capable of reprogramming at 
multiple stages of development, providing functional relevance to Notch1 and RBPJ 
ChIP-seq findings.  
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Outside of target accessibility, another potential explanation for the dichotomy observed 
in Notch signaling’s oncogenic potential during T lineage development is that obligate 
co-factors are only present prior to β-selection. Between the DN2 and DN3 stages, the 
transcription of many stem/progenitor legacy genes is extinguished, a large portion of 
which have known oncogenic roles (Rothenberg et al., 2010). Of particular importance, 
TAL1 mutations occur in approximately 60% of T-ALL cases and its expression is 
markedly downregulated in early thymocyte populations, along with its binding partners 
LMO1 and LMO2. Together, TAL1 and LMO proteins are understood to synergistically 
cooperate to promote T-ALL, if their expression is sustained (Chervinsky et al., 1999; 
Larson et al., 1996; Ono et al., 1997; Rothenberg et al., 2010; Van Vlierberghe and 
Ferrando, 2012). Notch1 mutations spontaneously occur in TAL1/LMO driven T-ALL 
mouse models, suggesting that the TAL1/LMO pre-leukemic thymocyte population is a 
highly permissive setting for oncogenic Notch (O'Neil et al., 2006). A recent and elegant 
study using cell competition to drive the first and only spontaneously occurring T-ALL 
model in WT thymocytes not only recapitulates the mutations and oncogenic progression 
found in human T-ALL, but also clearly illustrates that Notch mutations occur secondary 
to sustained TAL1/LMO expression (Martins et al., 2014). Together these findings 
suggest that Notch signaling may only be able to transform pre-leukemic populations, 
which is most commonly established by TAL1/LMO, and the factors needed to create 
this pre-leukemic state may only be expressed prior to β-selection.  
 
CRISPR technology now enables us to rapidly model and study complex transgenic 
combinations and could be utilized to test this hypothesis. Generation of Lck-cre x 
Tal1FL/FLICN1FL/FL mice, such that Tal1 is deleted in DN2 cells and ICN1 is expressed, 
should reveal whether or not the TAL1 complex is necessary for transformation by 
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Notch. In a converse experiment, CD4-cre x tgTal1FL/FLtgLmo1FL/FLICN1FL/FL mice could 
also be generated, such that TAL1, LMO1, and ICN1 are constitutively expressed after 
β-selection, and would test the hypothesis that ICN1 fails to transform T lineage cells 
later in development due to the lack of stem/progenitor legacy factors needed to 
establish a pre-leukemic population. Although the mechanism responsible for the switch 
in the Notch pathway’s oncogenic potential during T cell development remains unclear, 
the findings presented in this thesis provide the framework needed to address these 
questions in the future. 
 
Revisiting the linear instruction model of Th cell differentiation 
As discussed in Chapter 1, research over the past decade has increasingly challenged 
Mossman and Coffman’s Th1/Th2 paradigm and the linear instruction model. The 
identification of non-classical subsets such as Th17 and Treg cells, as well as the 
putative Th9 and Tfh populations, and the observation that Th cells can interconvert has 
not only invalidated a simplified bipotential model, but also directly questions whether Th 
cell subsets represent true lineages defined by rigid programs. While different cytokines 
clearly play a role in patterning and stabilizing individual Th cell programs, research has 
often overlooked the existence of a core network of activating signals shared by all Th 
subsets, derived from the TCR, costimulation, and as presented in this thesis, Notch 
receptors, as the linear instruction model discounts viewing Th cells as a single 
population. Researchers have attempted to apply the linear instruction model to all three 
of these pathways, however TCR, costimulation, and now Notch signaling have all been 
shown to influence the differentiation of multiple subsets in highly context dependent 
manner, rather than displaying any instructive capacity. From this perspective, it may be 
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more appropriate to view Th cells as a single lineage with the capacity to flexibly adopt 
multiple functional modules that form semi-stable effector states (Figure 4-3). 
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Figure 4-3: Hypothetical “modular” model of Th cell differentiation. When a naïve T 
cell sees its cognate antigen on an MHC-II-bearing antigen presenting cell (APC), it 
receives signals through a core Th cell signaling network consisting of the IL-1R, co-
stimulatory receptors, the TCR, and Notch receptors. Together, the terminal 
transcriptional effectors of these pathways construct a core platform of epigenetic 
architectures and transcription factor complexes, such that the cell is receptive to 
integrate unique signals from the given inflammatory environment. Shown is a 
hypothetical Th cell response during helminth infection. Signals derived from invading 
parasites are integrated into the core Th signaling platform and activate an anti-helminth 
Th cell response (classically Th2). Gata3 and other transcriptional effectors activate a 
modular network of transcriptional and epigenetic modifications that stabilize a Th2-like 
phenotype. Depending on other signals received by these cells, they may either activate 
a program that homes them to secondary lymphoid organs via a Bcl6-orchestrated 
network, or traffic to the site of inflammation using a Blimp1-dependent effector module. 
During the course of infection, these peripheral effector Th2-like cells may be exposed 
to factors that license the production of auxiliary cytokines, such as IL-9, and these cells 
may further be stimulated to turn on a Foxp3-regulated regulatory T cell transcriptional 
module to further tailor their function. If a secondary infection occurs, these peripheral 
Th2-like effector cells may adopt additional pathogen-specific programs, such as an 
anti-viral Th1 module, that enables these cells to participate in complex immune 
responses. Finally, some of the cells operating both a Th2-like and a Tfh module will 
turn off their anti-helminth response, while maintaining the Bcl6-governed module, and 
become central memory cells. 
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Recent studies looking at the epigenetics of lineage differentiation highlight how Th cell 
subsets are better represented as a single lineage with a large common regulatory 
network rather than multiple distinct populations. A seminal epigenetic study looking at 
global histone modifications in the various Th cell subsets found that few, if any, unique 
epigenetic architectures existed amongst the individual Th cell subsets. Only 3-7% of 
H3K4me3 labeled genes, denoting primed or active promoters, were unique to Th1, Th2, 
Th17, or Treg cells, with these subtypes diverging by 5-10% in terms of H3K27me3 
labeling, denoting primed or silenced genes. By comparison, thymus-derived natural 
Tregs diverged by 28% and 22% for H3K4me3 and K3K27me3 from the other Th cell 
populations, suggesting that differentiated Th cells are more similar than different, even 
when compared to a closely related population. Moreover, the signature genes for 
alternate Th cell programs were held in a poised chromatin conformation, indicating that 
these loci could readily be expressed upon stimulation. This is distinct from the loss of 
gene poising of lineage-specific factors during the differentiation of bona fide 
hematopoietic lineages (Cedar and Bergman, 2011; Wei et al., 2009). Outside of the 
canonical signature genes (i.e. Ifng and Tbx21 for Th1, Il4 and Gata3 for Th2, etc), 
global gene profiling revealed a high degree of similarity in Th cell transcription, even 
with regard to the transcription of genes thought to be selectively associated with only 
one Th cell subset (e.g. appreciable Il5 transcripts were observed in Th1, Th2, and Th17 
cells) (Wei et al., 2009). 
 
A more recent study analyzed enhancer usage amongst the different Th cells subsets 
and once again found a remarkable amount of epigenetic homology amongst these 
populations. Using p300 binding as a surrogate for enhancer usage, Vahedi and 
colleagues found that unlike distinct lineages such as macrophages or embryonic stem 
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(ES) cells, which respectively only shared ~10% and <1% of their enhancer usage with 
differentiated Th cells, Th1 and Th2 cells shared 65% and 55% of their enhancer usage 
together, despite these two cell types being considered mutually exclusive states with 
distinct transcriptional profiles. Not only do these cells exhibit similarity in global 
enhancer usage, but they also share a common transcription factor regulatory network. 
Even when enhancers specific to either Th1 or Th2 cells were analyzed for transcription 
factor motif enrichment, the top three motifs were shared by both subsets: AP1, RUNX, 
and NFAT. This particular finding further highlights the usage of a common signaling 
network by all Th cells, as AP-1 and NFAT are downstream effectors of TCR and co-
stimulation, respectively. In addition to these core-signaling factors, the GAS-3 motif, 
which is bound by STAT1 and STAT4, was found to be one of the most enriched motifs 
at both Th1- and Th2-specific enhancers (Vahedi et al., 2012). While STAT1 and STAT4 
are downstream of the Th1-associated cytokines IFNγ and IL-12, type-1 interferons can 
also activate STAT1 and it is interesting to speculate that these data implicate this 
important family of inflammatory mediators as a component of the core Th signaling 
network. In contrast to the shared motifs used by Th1 and Th2 cells, even at subset-
specific loci, a similar motif enrichment analysis performed at the enhancers of B cells, 
erythrocytes, CD4+ T cells, ES cells, and liver cells found almost no homology in 
transcription factor motif enrichment (Heinz et al., 2010). Collectively, epigenetic and 
transcriptional profiling of the Th cell subsets shows that, while these populations indeed 
represent unique functional programs, they display a striking degree of homology that is 
utterly lacking when similar analyses are performed on bona fide, distinct lineages. 
 
Viewing Th cells as a single lineage with a broad shared signaling network not is only 
more compatible with epigenetic and transcriptional data, but is also more in line with our 
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current understanding of Th cell plasticity. In this context, the “master regulators” can be 
understood to impart bundled and stackable effector properties. Tbet, Gata3, and Rorγt 
may be better appreciated as pathogen-specific programs tailored to home effector cells 
to the relevant tissue where they can properly eliminate invaders, rather than lineage 
reprogramming factors. These pathogen-specific programs could be overlaid with a 
regulatory program (Foxp3), a germinal center/central-memory program (Bcl6), a 
peripheral tissue effector program (Blimp1), or licensed to produce additional accessory 
cytokines (IL-9), in order to tailor nuanced local responses. Given unique classes of 
pathogens require different immune responses and it is necessary to maintain a stable, 
coherent response until a pathogen is cleared, it is not surprising that the pathogen-
programming factors (Tbet, Gata3, and Rorγt) tend to be expressed independently of 
one another and we fail to observe the spontaneous introversion of Th cells in classic 
infection models. Moreover, as Th cells have such a robust core signaling network, there 
is a need for factors that permit T cells to efficiently adopt individual anti-pathogen 
programs. In this light, the findings reported in Chapters 2 and 3 demonstrate that the 
Notch pathway is a component of the core Th cell signaling network that allows for the 
rapid diversion of an activated cell into one of these semi-stable, pathogen-specific 
functional programs (Figure 4-4). Thus Notch is not essential for differentiation if 
exogenous factors can robustly activate these programs alone, but inhibition of Notch 
signaling during immune responses with weak or complex inflammatory milieus results in 
the marked destabilization of Th cell differentiation, as seen in a wide variety of models 
(Billiard et al., 2012; Fang et al., 2007; Jiao et al., 2014; Park et al., 2013; Tran et al., 
2013; Zhang et al., 2011).  
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While the classical linear instruction model remains useful for conceptualizing the unique 
properties of each Th cell subtype, it is in inadequate for predicting the behavior of the 
signaling molecules and transcription factors participating in Th cell differentiation, other 
than those involved in cytokine signaling. By modeling Th cell differentiation as a single 
lineage capable of adopting multiple, overlaid functional modules, there becomes less of 
a need to understand how these programs are rigidly enforced and a greater need to 
understand how the multitude of signals that activated T cells receive are coherently 
integrated to give the illusion of distinct lineages. Moreover, increased emphasis is 
needed to understand how exogenous factors modify the outputs derived from the core 
signaling network, rather than looking for how these factors lead to a linear in-put/out-put 
within a single signaling pathway. 
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Figure 4-4: Notch and the hypothetical “modular” model. Notch acts to promote 
the integration of inflammatory modules into the core Th signaling platform, while 
destabilizing the integration of regulatory modules. When CD4+ T cells are 
activated, the core Th signaling platform inefficiently integrates both inflammatory 
and regulatory modules. When Notch signaling is engaged, inflammatory modules 
are readily integrated, while regulatory modules are excluded. In contrast, when 
Notch signaling is inhibited, inflammatory modules are poorly integrated and 
regulatory modules are utilized. 
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Applying the signal integration model of Notch to other developmental processes 
It is not surprising that the first Notch-dependent phenotypes described were those 
involved in fate choice decisions, as these phenotypes provided robust all or none 
results in genetic studies (Guruharsha et al., 2012). However, recent work on Notch 
signaling has highlighted how this classically instructive pathway can be involved in the 
development of multiple closely related lineages in the hematopietic system. Innate 
lymphocytes (ILCs) are an innate immune population that shares both functional and 
developmental properties with T lineage cells. Not only are ILCs subfractionated using 
identical functional criteria as Th cells (with ILC1s producing Th1-like cytokines, ILC2s 
producing Th2-like cytokines, and ILC3s producing Th17-like cytokines), but they also 
share some of the core T lineage transcriptional network. Gata3, Tcf1, and Notch 
signaling have all been shown to play roles in ILC development and it has been 
suggested that this implies an evolutionarily conserved transcriptional network shared 
between ILCs and thymocytes (Tait Wojno and Artis, 2012; Yang et al., 2013). Notch 
signaling is thought to be involved in both ILC2 and ILC3 development. Two different 
populations of ILC3s, lymphoid tissue inducer cells (LTi) and IL-22 producing ILCs 
(ILC22s), require Notch signaling during development and ILC2 development is similarly 
dependent on Notch signaling both in vitro and in vivo (Cherrier et al., 2012; Lee et al., 
2011; Wong et al., 2012b; Yang et al., 2013). If one envisions that the role Notch plays in 
ILC development occurs along similar lines as its unbiased role in Th cell differentiation, 
then one would predict that Notch signaling does not instruct individual ILC subsets, but 
rather allows for efficient differentiation and/or function of all three ILC subtypes when 
conditions are otherwise not permissive. Notably, ILC22 development is only impaired in 
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the lamina propria, but not the Peyer’s patches, in the absence of RBPJ, consistent with 
the notion that the requirement for Notch may depend on whether the exogenous 
differentiating cues present in a given environment are limiting, rather than an absolute 
necessitation for the pathway (Lee et al., 2011). While it remains to be seen whether 
Notch signaling is also involved in ILC1 development, future studies of Notch and ILC 
biology should take caution in ascribing instructional activities to the pathway when an 
unbiased, signal integrating model may be a more effective means of understanding how 
Notch functions within this lineage. 
 
In addition to ILCs, recent studies have also uncovered unappreciated roles for Notch 
signaling in DC development and function. Though Notch signaling had previously been 
implicated as an important factor in DC development, where it was thought to be 
involved in the expansion of pre-DC populations, the extent to which it regulates multiple 
subsets has only been revealed (Cheng et al., 2003). Studies have now implicated 
Notch signaling in the development of conventional DCs, splenic CD8- DCs, 
plasmacytoid DCs (pDC), thymic Thy1+ DCs, EsamHiCD11b+ DCs, CD11b+CD103+ DCs, 
and even human DC populations (Caton et al., 2007; Ishifune et al., 2011; Lewis et al., 
2011; Li et al., 2008; Olivier et al., 2006; Zhou et al., 2009a). Moreover, the Notch 
pathway is important in regulating cytokine and chemokine production in multiple DC 
populations following activation (Bugeon et al., 2008; Gentle et al., 2012; Hu et al., 2008; 
Perez-Cabezas et al., 2011; Svensson et al., 2010). Paralleling its activity in Th cell 
differentiation, Notch signaling has also been suggested to regulate DC development 
and function by integrating exogenous stimuli, including TLR ligands and IFN signaling 
(Gentle et al., 2012; Hu et al., 2008; Svensson et al., 2010). Viewing the role of Notch in 
DC biology as an integrator of exogenous signals, rather than a lineage instructor, not 
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only is more consistent with the current literature, but also fits with our understanding of 
DCs as a dynamic lineage that persists in a wide range of tissues and 
microenvironments. In this manner, Notch signaling could be understood to allow DCs to 
efficiently and robustly adapt to a given environment and adopt an appropriate function 
and fate for a given immune response, even in the face of a complex inflammatory 
milieu. Further highlighting the similarities in Notch function in Th cell and DC biology, 
while Notch signaling has been implicated as an important regulator of inflammatory DC 
function, inhibition of Notch signaling has been found to expand a population of DCs with 
the capacity to induce Treg differentiation, leading to an accumulation of Tregs in vivo 
(Billiard et al., 2012). Though this is only one report, it is tantalizing to speculate that the 
Notch pathway functions similarly in both DCs and Th cells in order to coordinate 
inflammation, at the expense of regulatory responses, thus resulting in the synergistic 
induction of robust inflammatory responses. Taking this hypothesis further, it would also 
predict that systemic inhibition of Notch signaling would be particularly efficacious in 
resolving inflammation and promoting regulatory function, and indeed this phenomena 
has been observed for models of arthritis, EAE, type-1 diabetes, and GvHD (Billiard et 
al., 2012; Jiao et al., 2014; Park et al., 2013; Tran et al., 2013; Zhang et al., 2011). 
Whether or not Notch plays a non-instructional role in other developmental processes 
remains to be tested, but recent work on ILCs and DCs illustrates the utility of the signal 
integration model in interpreting these findings and generating hypothesis for future 
studies. 
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Materials and Methods 
Mice 
ROSA26-DNMAML mice were previously described (Tu et al., 2005). C57Bl/6 mice were 
obtained from the National Cancer Institute (Frederick, MD). ICN1 transgenic mice were 
a kind gift from Douglas Melton (Harvard University, MA) and crossed with CD4-Cre 
(Taconic, NY) or Foxp3-Cre (from Alexander Rudensky, at Memorial Sloan Kettering 
Cancer Center, NY). Tbx21-/- mice were generously provided by John Wherry (University 
of Pennsylvania, PA). YFP mice, Rag1 deficient mice, SJL mice and C57BL/6 were 
obtained from Jackson Laboratories (Bar Harbor, ME).  All mice were housed in specific 
pathogen-free facilities at the University of Pennsylvania. Experiments were performed 
according to the guidelines from the National Institutes of Health with approved protocols 
from the University of Pennsylvania Animal Care and Use Committee. 
 
TAT-Cre 
Expression of TAT-cre was induced with IPTG in bacteria during log phase of growth at 
37°C in the presence of chloramphenicol and carbenicillin. The Children’s Hospital of 
Pennsylvania Protein Core carried out purification of TAT-Cre protein. 107 CD4+ T cells 
from DNMAMLFL/FL or YFPFL/FL mice were MACS purified by positive selection with CD4 
Microbeads (Miltenyi). Subsequently, cells were washed, resuspended in 1 ml serum-
free OPTI-MEM (Life Technologies), and incubated with 1 ml of 100 mg/ml of TAT-Cre in 
OPTI-MEM for 12 min at 37oC. Cells were then washed and cultured in IMDM (Life 
Technologies) supplemented with 10% heat-inactivated FBS, 100 U/ml penicillin, 100 
mg/ml streptomycin, 2 mM L-glutamine, 50 mM 2-mercaptoethanol, and 100ng/mL IL-7. 
Twenty-four hours later, naïve YFP+ or GFP+ CD4+ T cells were FACS sorted 
126 
 
 
Quantitative PCR 
RNA was extracted using the QIAGEN RNeasy Mini Kit. cDNA was synthesized from 
RNA with the Superscript II kit (Invitrogen). Transcripts were amplified with Sybr Green 
PCR Master Mix (ABI) and quantitative PCR was performed on an ABI ViiA 7 Real-Time 
PCR System. (Primers, Table S1) 
 
Chromatin immunoprecipitation assays  
Chromatin immunoprecipitation (ChIP) was performed as described previously (Yashiro-
Ohtani et al., 2009). Briefly, chromatin samples were prepared from fixed 6 million cells 
and immunoprecipitated with rabbit immunoglobulin G (#sc-3888; Santa Cruz 
Biotechnology, Santa Cruz, CA) or anti-Notch1 antibodies (Aster et al., 2000). Purified 
DNA was subjected to real-time polymerase chain reaction (PCR) with primers flanking 
RBPJ binding sites at Gata3-1a, Il4 HS5, IFNg CNS-22, or Tbx21 promoter (primers, 
Table S2). CD4+ T cells from Notch1 null mice were used for an immunoprecipitation 
negative control. Nanog was used as an internal negative control. The DNA quantity 
recovered from each ChIP sample is shown as the relative value to the DNA input 
sample.  
 
Luciferase assay 
Ifng luciferase constructs are described (Hatton et al., 2006). Constructs included a 
reporter control (pGL3), the reporter plus a 468 bp Ifng minimal promoter (ProWT), the 
minimal promoter construct containing a mutated T-box binding site (ProMT), the minimal 
promoter construct with a WT Ifng CSN-22 upstream (ProWTCNSWT), the WT CNS-22 
construct containing a mutated T-box binding site in the promoter region (ProMTCNSWT), 
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the Ifng CNS-22 construct with the upstream CNS-22 T-box half-site mutated 
(ProWTCNSMT1), and the Ifng CNS-22 construct with the downstream CNS-22 T-box half-
site mutated (ProWTCNSMT1). Point mutations to T-box binding sites in the Ifng promoter 
were made using the Promega QuikChange Site Directed Mutagenesis Kit. Constructs 
were sequenced to prove authenticity. 2 X 105 Jurkat cells were plated in triplicate and 
transfected with 50 ng of the indicated promoter/reporter constructs, 25 ng pRL-TK, and 
100 ng pcDNA-ICN1 or vector control using DMRIE-C (Invitrogen). Transfected cells 
were cultured overnight and then stimulated for 4 hours with 20 ng/mL PMA and 200 
ng/mL ionomycin. 2 x 104 U2OS cells were plated in triplicate and transfected with 50 ng 
of the indicated promoter/reporter constructs, 10 ng pRL-TK, 10 ng pcDNA-ICN1 or 
vector control, and 25 ng Mig-Tbet or vector control using FuGENE 6 (Promega). After 
stimulation, firefly substrate activity was measured using Britelite Plus (PerkinElmer) and 
renilla substrate activity measured using Stop & Glo (Promega). Firefly values were 
normalized to Renilla and then all normalized values set relative to the pGL3 control 
vector. All measurements were performed using a GloMax-96 Microplate Luminometer 
(Promega). 
 
In vitro T cell culture 
Lymph nodes from WT mice were CD4+ MACS purified and then naïve CD4+ T cells 
were FACS sorted. Naïve CD4+ T cells were co-cultured with irradiated, Thy1.2 depleted 
splenocytes at a 1:5 ratio and stimulated using anti-CD3e (1 µg/mL), and anti-CD28 (1 
µg/mL) mAb. Cells were cultured under either neutral (5 ng/mL IL-2, 20 µg/mL anti-IL-4, 
and 20 µg/mL anti-IFNγ), Th1 (5 ng/mL IL-2, 5 ng/mL IL-12, and 20 µg/mL anti-IL-4), 
Th2 (20 ng/mL IL-4, 20 µg/mL anti-IFNg, and 20 µg/mL anti-IL-12), Th9 (10 ng/mL IL-4 
and 5ng/mL TGF-β), Th17 (20 ng/mL IL-6 and 5ng/mL TGF-β), or Treg (5 ng/mL IL-2 
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and 5ng/mL TGF-β) culture conditions. For titration experiments, the conditions listed 
above were used for 1x dilutions and all other dilutions were made from this stock. For 
GSI experiments, cells were treated with either DMSO or 1 µM GSI.  
 
Adoptive T cell transfer 
Total T cells and non-T cells from spleen and lymph nodes of CD4Cre-YFP mice or 
CD4Cre-ICN1 mice were purified and sorted with thy1.2 Abs. CD4 T cells and CD8 T 
cells from spleen and lymph nodes of CD4Cre-YFP mice or CD4Cre-ICN1 mice were 
positively selected with thy1.2 (30-H12) then sorted with anti-CD4 (RM4-5) and anti-
CD8a (53-6.7) 2 × 106 cells were transferred to B6 mice and frequency of Gr1+(RP6-
8C5) and CD11b+ (M1/70) population in peripheral blood were analyzed after 4 weeks 
of transfer. 
 
Mixed bone marrow chimeras 
5FU treated BM cells (BMCs) from WT (SJL) and CD4Cre-ICN1 mice were adoptively 
transferred into sub-lethally irradiated (500 rad) Rag1 deficient mice with 1:1 mixture of 
BMCs from WT (CD45.1; 2 × 106 BMCs) and/or CD4Cre-ICN1 (CD45.2; 2 × 106 BMCs) 
mice. Recipient Rag1 deficient mice were treated with acidified, antibiotic water 1 week 
before to 2 weeks after the irradiation and then switched to acidic water without 
antibiotics for 4 weeks. Mice were analyzed 6 weeks after the transfer. 
 
Measurement of cytokines 
For intracellular cytokine staining, cells were restimulated, fixed, and stained as 
described (Tu et al., 2005). Cells were stained with anti-CD4 (RM4-5, Biolegend), anti-
IFNγ (XMG1.2, BD), anti-IL4 (11B11, eBioscience), anti-IL17A (ebio17B7, eBioscience), 
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anti-Tbet (eBio4B10, eBioscience), and anti-GATA3 (L50-823, BD). Cells were acquired 
on a LSRII (Becton Dickenson) and data was analyzed with FlowJo (TreeStar). ELISA 
was performed as described (Tu et al., 2005). 
 
GSI-washout assay 
WT CD4+ T cells were stimulated as above and 24 hours post-stimulation cells were 
treated with either DMSO or GSI (1 µM) for 20 hours. Subsequently, T cells were CD4+ 
MACS purified and cells cultured in media containing cycloheximide (20 µg/mL) and 
cells previously cultured DMSO were replated in DMSO and cells cultured in GSI were 
either replated in 1 µM GSI or in DMSO for 4 hours. RNA was then harvested and 
analyzed by qPCR. 
 
T. muris infection and antigen 
T. muris eggs were prepared as described (Tu et al., 2005). Mice were infected on day 0 
with 150–200 embryonated eggs, and parasite burdens were assessed on day 21 after 
infection. Mesenteric LN (MLN) cell suspensions were prepared and resuspended in 
IMDM supplemented with 10% heat-inactivated FBS, 100 U/ml penicillin, 100 g/ml 
streptomycin, 2 mM L-glutamine, and 50 M 2-mercaptoethanol. Cells were plated at 4 X 
106 cells/well and cultured in the presence of anti-CD3e and anti-CD28 for 72 hours. 
Levels of IL-4, -5, and -13 were assayed by sandwich ELISA. For histology, segments of 
mid-cecum were removed, washed in sterile PBS, and fixed for 24 hours in 
paraformaldehyde. Tissues were processed and paraffin embedded using standard 
histological techniques. For detection of intestinal goblet cells, 5 µm sections were cut 
and stained with hematoxylin and eosin or Alcian blue periodic acid Schiff. Analysis of 
parasite- specific IgG1 and IgG2c production was performed by antigen capture. 
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